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LITERATURE REVIEW 
Maize Dwarf Mosaic Virus 
In 1964, Dale (24) isolated a mechanically transmis-
sible phytopathological agent which ellicited mosaic 
symptoms on corn (Zea mays) and sorghum (Sorghum bicolor). 
The causative agent, identified as a virus, was designated 
maize dwarf mosaic virus strain A (MDMV-A) and is now 
considered to be the most widely occurring viral pathogen 
of corn in the United States (122, 123). MDMV-A can be 
distinguished from closely related sugarcane mosaic virus 
(SCMV) strains by the ability of the former to replicate 
in Johnsongrass (Sorghum halepense) but not sugarcane 
(Saccharum spp.). Today, most researchers use the virus 
designation MDMV; however, some refer to MDMV-A as the 
Johnsongrass strain of SCMV or SCMV-Jg (110, 138). In 
1966, MacKenzie et al. (91) isolated a new strain of MDMV 
from corn which did not replicate in Johnsongrass. This 
strain was designated MDMV-B. Other strains of MDMV 
include MDMV-C, MDMV-D, MDMV-E, MDMV-F, and MDMV-0 (90, 
94); however, only MDMV-A and MDMV-B are considered to be 
economically important pathogens of corn and sorghum 
(141). 
MDMV is a member of the largest group of plant 
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viruses, the potato virus Y group. Members of this group 
have characteristic flexuous filamentous particles, nor-
mally 720-900 nanometers (nm) long and 11 nm in diameter 
(47, 57). The genome consists of a single stranded, 
positive sense, ribonucleic acid (RNA) molecule, with a 
molecular weight of 3.0-3.5 megadaltons (47, 52, 54, 57). 
The RNA genome is enclosed within the particle by up to 
2000 repeating subunits of a single protein species 
(molecular weight 3.0-3.7 kilodaltons) arranged in a helix 
(47, 51, 54, 57, 83). Definitive members of the potato 
virus Y group are transmitted non-persistently by aphids 
and induce the formation of characteristic cytoplasmic 
inclusions (21, 57, 68, 95). Cytoplasmic inclusions are 
unique to the potato virus Y group and can be useful for 
the diagnosis of infection at the group level (33, 47). 
MDMV is an important phytopathological agent of maize 
where it can potentially reduce corn grain yields by as 
much as 45% (122). Symptoms induced by MDMV in maize 
include local and systemic necrosis, systemic mosaic, 
dwarfing, and occasionally leaf reddening (54, 109, 110, 
111). The development of various symptom patterns depend 
upon host genotype (11, 111, 139), virus strain (34, 109, 
121), time of inoculation (63, 122), and certain environ-
mental factors including temperature (45, 67, 129) and 
light (67, 129). Infected plants also exhibit numerous 
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physiological and biochemical changes including the forma-
tion of viral coded cytoplasmic inclusions (21, 57, 68, 
95), unusual aggregates of mitochondria and chloroplasts 
(57), reduction in transpiration rate (88), decreased ear 
diameter, length, and width, (20, 97), sterility expressed 
as missing kernels (98), stunting (109), reduction of 
stalk diameter and strength (73), and a reduction in seed 
quantity and quality (20, 97). 
MDMV has an extensive host range, infecting more than 
200 members of the Gramineae (120, 141). Of the two major 
strains used in this study, strain A has a wider geograph-
ical range and taxonomic distribution within the Gramineae 
than strain B (120, 121, 123). Furthermore, many grasses 
which are hosts to both strains produce less severe 
symptoms when infected with MDMV-B (121). Within the 
Gramineae, Johnsongrass has been recognized as the prin-
cipal reservoir for MDMV-A survival. In addition, Knoke 
et al. (76) have shown that infected Johnsongrass is the 
main virus source for initial vector acquisition and 
subsequent spread to maize. 
The means by which MDMV-B overwinters is still 
unknown. The virus has a limited perennial grass host 
range; none of these species have been shown to harbor 
MDMV-B. Evidence does exist for a low incidence of MDMV-B 
transmission through corn seed (56, 61, 130); thus, it 
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would seem entirely possible that seed transmission in 
wild grasses could serve as the primary virus source. 
MDMV can be mechanically transmitted; however, aphid 
vectors seem to be the major source of spread within the 
field. As with all members of the potato virus Y group, 
MDMV is transmitted by aphids in a non-persistent or 
stylet-borne manner. Acquisition of MDMV occurs when 
aphids alight on a leaf surface and make brief stylet 
probes (usually less than 30 seconds) into the leaf 
epidermal cells. These probes are presumably to test the 
suitability of the leaf as a food source. Upon regurgita-
tion of the plant sap the virus absorbs to the dry stylet 
surface (96). Once acquired, the virus can be transmitted 
immediately to one or only a few healthy plants during 
subsequent inoculation probes (93). Viruses transmitted 
non-persistently cannot multiply or circulate within their 
vectors. Therefore, the ability of viruliferous aphids to 
transmit non-persistent viruses typically persists for 
only 1-4 hours following acquisition. However, Berger 
(8), has shown that the MDMV vector Schizaphis graminum 
can remain viruliferous for up to 21 hours following 
acquisition. Due to the stylet-borne mode of transmis-
sion, MDMV has a low level of vector specificity and 
therefore can be transmitted by at least 26 aphid species 
(75, 116, 141). MDMV-B has also been shown to be trans-
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mitted through soil; however, the soil inhabiting vectors 
have not been identified (12). 
The extent of an MDMV epiphytotic is dependent upon 
the number and proximity of primary virus sources, the 
gradation of aphid vector populations, and the suscep-
tibility or resistance of the maize hybrids grown in the 
region (162). Therefore, control of MDMV can be attempted 
in a variety of ways. Eradication of the primary virus 
source would serve as one method of control. However, as 
noted previously, the primary source of MDMV-8 is not 
known. In addition, the large perennial host range of 
MDMV-A would make eradication an expensive and incomplete 
control measure. 
Control of vectors is another possible way to limit 
virus spread. This usually involves the reduction of 
aphid populations with systemic insecticides. Although a 
viruliferous aphid will be killed by a systemic insec-
ticide, MDMV can be transmitted in a single leaf probe. 
The use of leaf oils, which inhibit aphid probing be-
havior, have been suggested for the control of non-
persistent transmitted viruses. However this method is 
expensive and short-lived (141). 
Undoubtedly the most successful and widespread con-
trol method for MDMV is breeding for resistance or 
tolerance. This process involves the selection of resis-
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tance or tolerance genes and the subsequent breeding of 
these genes into a cultivar genome which exhibits accept-
able agronomic characteristics. Although tolerance and 
resistance are the control methods of choice, each has its 
limitations. Infected tolerant plants allow the replica-
tion of virus; however, symptoms are suppressed. This may 
not be an acceptable solution, for tolerant plants may 
serve as a reservoir for the spread of virus to other 
hosts (93). Resistant plants do not allow the replication 
of virus; however, Findley et al. (34) and Presley et al. 
(111), have shown that resistance to MDMV is strain 
specific. Furthermore, almost all corn inbred lines which 
demonstrate varying degrees of resistance to MDMV-A are 
highly susceptible to MDMV-B (121). Because of this in-
herent problem, it would be desirable to index a maize 
plot and determine if a 11 resistant 11 host is infected with 
one or more strains of MDMV. 
Several methods exist for differentiating the two 
major strains of MDMV. Use of differential hosts (corn 
inbred line E663 for MDMV-A and Setaria adhaerans for 
MDMV-B) has been suggested by Rosenkranz (119) and Tosic 
and Ford (144). However the use of these hosts is 
impractical. Only a small percentage of MDMV-B inoculated 
hosts will produce symptoms and symptom development for 
both viruses may take 7-14 days (121). In addition, 
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valuable greenhouse space must be expended to harbor the 
assay plants. The problems inherent with biological 
assays can be alleviated through the use of immunological 
assays. These assays have the potential for very high 
sensitivity and strain specificity. Furthermore, im-
munological assays could easily accommodate the indexing 
of numerous samples in a relatively short period of time. 
On the other hand, immunological assays detect antigenic 
sites on the virus; which may not be an accurate measure-
ment of infectious viral particles. 
Application Of Immunoassays To Plant Virology 
Plant virologists have made increasing use of 
serological methods as a sensitive and specific tool for 
the indexing of plant viruses. When viral antigen com-
bines with specific antibody, a precipitate forms which is 
visible with the unaided eye or a binocular microscope. 
The extent of precipitation is dependent upon a number of 
factors including salt concentration, pH, temperature, 
and, most importantly, the ratio of concentration of 
antibody and viral antigen. If excess of either antibody 
or antigen exists, inhibition of precipitation may occur. 
The concentration of antiserum and antigen which results 
in the optimal precipitation is termed the concentration 
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of equivalence for that specific antiserum and virus 
system. Some of the more commonly utilized immunological 
assays based upon the precipitation reaction include 
microprecipitin (153), passive hemagglutination (125), and 
Ouchterlony gel diffusion (105). 
The microprecipitin test is primarily utilized for 
determining specific antiserum titer and the concentration 
of equivalence. The reaction of a virus with a specific 
antiserum is clearly visualized if a series of twofold 
dilutions of both reactants are mixed in all combin-
ations. The inverse of the highest antiserum dilution 
which develops a visible precipitate is termed the titer 
of that antiserum. The concentration of equivalence 
occurs at the antiserum and virus dilution which elicits 
the first visible precipitate. 
Passive hemagglutination is a modified form of the 
microprecipitin test. Viral antigen or specific antiserum 
are non-specifically adsorbed to sensitized sheep red 
blood cells (SRBC). With the addition of small amounts of 
the other reactant, the sensitized SRBC form a large, 
easily visible precipitate. The usefulness of micro-
precipitin and hemagglutination assays as index i ng tools 
is limited due to the non-specific aggregation of plant 
chloroplasts and other cellular debris in the liquid 
medium (2). These problems can be eliminated by performing 
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the precipitation reaction in a gel medium. 
Since its introduction in 1962, Ouchterlony gel 
diffusion has been one of the more popular techniques 
utilized to assay plant viruses. Briefly, wells are 
formed in some defined geometrical pattern in a thin layer 
of agar. The specific antiserum is usually placed in a 
central well and the viral antigen solutions in surround-
ing wells. Virus and antiserum diffuse towards one 
another through the agar and form a precipitation line 
where the two reactants are present in optimal 
proportions. The formation and position of a precipita-
tion line is completely dependent upon a balanced system 
of virus and antiserum (6). Therefore, one must determine 
the concentration of equivalence for each antibody-antigen 
system studied. An optimized assay can detect 1-2 ug/ ml 
of virus (38) and has been the basis of several commercial 
screening programs (26, 93). In addition, the Ouchterlony 
double diffusion assay has been used to determine 
serological relationships between closely related viruses 
(1, 99). Problems associated with the use of gel diffu-
sion assays include viral aggregation resulting in ar-
tifacts and the diffusion of rod shaped particles, such as 
MDMV, may be restricted due to particle shape. Degrada-
tion of viral particles prior to diffusion has been sug-
gested; however, this process may destroy viral epitopes 
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(6, 55, 93). 
For many important plant viruses, serological tech-
niques performed in liquid or gel media cannot be utilized 
because of certain limitations such as low virus con-
centration, unsuitable particle morphology, or the 
presence of aggregating cellular debris in cell extracts. 
These problems can be eliminated through the use of solid-
phase supports, which immobilize reagents to a solid 
surface. These assays are based upon the observation that 
proteins will hydrophobically interact and nonspecifically 
bind to plastic surfaces (86). Some of the most commonly 
used solid-phase assays include serologically specific 
electron microscopy (7), enzyme-linked immunosorbent assay 
(22), radioimmunoassay (5), and, most recently, dot im-
munobinding assay (49). 
Serologically specific electron microscopy (SSEM) was 
first introduced by Ball and Brakke (7). The original 
procedure has been modified in various ways to produce a 
rapid diagnostic test (106). Briefly, electron microscopy 
grids coated with a plastic membrane are floated on 
specific antiserum. Unbound antiserum is removed by 
washing and the grid is immediately floated on 50 ul drops 
of infected tissue extracts. Viral particles immobilized 
on the grid are then stained and observed under the 
electron microscope . SSEM was found to be much more 
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sensitive than gel diffusion and, in some cases, more 
sensitive than enzyme-linked immunosorbent assay (48). 
Furthermore, Alexander and Toler (3) have coupled SSEM 
with immuno-gold decoration to differentially label viral 
particles of MDMV-A and MDMV-B in a mixed preparation. 
Although SSEM is very sensitive and highly specific, the 
technique requires considerable training, expensive equip-
ment, and is time consuming. Therefore, this technique 
would not be well-suited for the routine analysis of a 
large number of samples. 
I~ 1977, Clark and Adams (22) showed that enzyme-
linked immunosorbent assay (ELISA) could very efficiently 
be applied to the rapid and sensitive detection of plant 
viruses. This technique couples the use of a polystyrene 
solid-phase with specific antibody conjugated with 
enzyme. For plant viruses, the double-sandwich form of 
ELISA has been found to be suitable (155). In this 
method, specific antibody adsorbed to a polystyrene 
microtitration plate selectively traps and immobilizes 
virus in extracted tissue. Captured virus is further 
reacted with specific antibody to which an enzyme has been 
conjugated. After washing, enzyme conjugated antibody 
bound to virus is detected colorimetrically by the addi-
tion of a suitable enzyme substrate. 
Generally, the system described above can detect 
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virus at concentrations of 10-100 ng/ml (89, 155); 
however, Clark and Adams (22) have reported detection 
levels below 1 ng/ml. This method can easily be applied 
to the indexing of a large number of samples in a rela-
tively short period of time. For example, the double-
sandwich ELISA (ds-ELISA) has been used to assay in-
dividual soybean seeds and leaf extracts for the presence 
of tobacco mosaic virus and soybean mosaic virus (53, 
89). In addition, Sum et al. (137) have shown that ELISA 
was 100 times more sensitive than infectivity tests for 
the detection of MDMV. However, one major limitation has 
been encountered with the ELISA technique. 
Koenig (77) reported that the binding of enzyme 
conjugated antibodies in an ELISA was completely inhibited 
by simultaneously added native antibodies. She suggested 
that the harsh conjugation procedure may alter the an-
tibody molecule or the enzyme may allosterically hinder 
the binding sites; thus, reducing the binding abilities of 
the antibodies. In some cases the enzyme conjugation 
procedure may reduce antibody binding by 60-88 % (40). 
This problem can be circumvented through the use of solid-
phase radioimmunosorbent assay (RIA) with radiolabelled 
antibody (40, 62). 
The first RIA used for the detection of plant viruses 
was developed by Ball in 1973 (5). Her assay was based 
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upon the ability of sample antigen to compete with 
labelled antigen for binding to a limited number of an-
tibody molecules. Briefly, specific antibody is irrevers-
ible adsorbed to the walls of polystyrene disposable 
centrifuge tubes. A specified amount of radiolabelled 
virus is added simultaneously with tissue extract contain-
ing an unknown amount of unlabelled virus. The amount of 
captured labelled virus can be measured and is inversely 
proportional to the amount of virus in the test sample. 
This assay is fairly sensitive and specific; however, it 
requires the labeling of purified virus. Therefore, use 
of such a system with viruses that are difficult to purify 
would not be economically feasible. 
In 1980, Ghabrial and Shepherd (40) developed a 
microtitration plate RIA based upon the principal of the 
double-antibody sandwich described previously. Their RIA 
required the radioiodination of purified antiserum rather 
than viral antigen. Using polystyrene microtitration 
plates as the solid-phase, this assay was performed much 
like the ds-ELISA of Clark and Adams (22); however, addi-
tion of enzyme-conjugated antibody is replaced by 
radiolabelled antibody. This assay requires an additional 
step as bound radiolabelled antibody must be disassociated 
from the virus by acidification. The released radioac-
tivity is then measured in a scintillation counter. Thi s 
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RIA was 10 times more sensitive than ELISA when detecting 
the presence of lettuce mosaic virus in tissue extracts 
(40). Therefore, RIA offers an alternative to ELISA for 
systems where the latter gives borderline or inconclusive 
results due to insufficient sensitivity. Furthermore, in 
1983 Bryant et al. (17) designed a solid-phase double 
antibody sandwich RIA which utilizes antibody coated 
polystyrene beads rather than polystyrene microtitration 
plates. Therefore, to measure the bound labelled antibody 
one simply places the entire bead into a scintillation 
vial with 5.0 ml of Riafluor scintillation cocktail. This 
assay eliminates the need to disassociate and isolate 
bound labelled antibody from the virus. Thus the time 
required to perform this RIA is the same as a ds-ELISA. 
In addition, recent tritium labelling procedures provide a 
simple, gentle, and efficient procedure for radiolabelling 
antibodies without loss of biological activity (69). On 
the other hand, the use of ELISA has certain advantages 
over RIA including economic preparation and long shelf 
life of enzyme conjugated reagents, freedom from 
radiological safety procedures, and results which can be 
scored visually or with simple inexpensive equipment. 
Most recently, Hibi and Saito (49) have developed a 
sensitive dot immunobinding assay (DIBA) based upon the 
immunobinding techniques of Towbin et al. (147) and the 
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principles of ds-ELISA. This assay is performed much like 
a ds-ELISA. However, nitrocellulose filter paper is 
utilized as the solid-phase support rather than polys-
tyrene and the product of the enzyme reaction is 
insoluble. Using their procedures, Hibi and Saito (49) 
could complete a DIBA in 4-5 hours and detect 1 ng/ml of 
tobacco mosaic virus in tissue extracts. However, at low 
tissue dilutions they observed high non-specific reactions 
with plant extracts. These non-specific reactions per-
sisted when antiserum cross adsorbed with plant tissue was 
used. Therefore, this technique would not be useful for 
detecting the presence of viruses which typically occur at 
low concentrations in their host. Although some technical 
improvements are necessary to reduce non-specific reac-
tions, this assay may prove to be a simple more rapid test 
than ELISA for indexing tissue extracts. 
Antiserum typically utilized in irranunoassays consists 
of a heterogenous population of antibody molecules. The 
characteristics of a particular antiserum are dependent 
upon the affinity, avidity, and specificity of each an-
tibody molecule within the mixed population. Therefore, 
specific antiserum derived against one antigen could very 
possibly contain antibody molecules which will cross-react 
with a closely related heterologous antigen. This occurs 
if the antigens possess certain conserved epitopes which 
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are recognized by the immunized animal as common to both. 
This situation exists with strains A and B of MDMV (64, 
109, 133). Therefore, an immunoassay developed using 
antiserum derived against MDMV-A, will not only detect the 
presence of MDMV-A but will also detect the heterologous 
strain MDMV-B. Normally this would not be a problem; 
however, Pioneer Hi-Bred International, Inc. has expressed 
interest in a rapid, strain specific, immunoassay for the 
detection of MDMV to be utilized in their breeding 
program. 
The majority of antibodies specific for conserved 
viral epitopes can be removed through extensive cross-
absorbtion with the heterologous strain; however with 
their great sensitivity, most immunoassays can detect even 
very small amounts of cross-reacting antibody. Alterna-
tively, problems inherent with conventional heterogenous 
antiserum can be eliminated through the use of monoclonal 
antibodies (McAbs). 
The clonal selection theory proposed by Burnet (18) 
states that an antibody-producing B-cell is committed to 
generating homogenous antibody molecules with the same 
affinity, avidity, and specificity. A B-cell can become 
cancerous like any other cell. The result is a single 
cell myeloma whose clones secrete a homogenous population 
of antibody molecules or McAbs. The induction of myelomas 
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is a completely random process; therefore, it would be 
difficult to isolate a McAb producing myeloma specific for 
a particular antigen. 
In 1975, Kohler and Milstein (79) developed a method 
to solve this dilemma. They fused an antibody secreting 
spleen cell from an immunized animal with a myeloma cell. 
The result is an immortal 11 hybridoma 11 which secretes a 
McAb of predetermined specificity, characteristic of the 
spleen cell. Using this technique, cell lines producing 
McAbs of almost any specificity can be obta i ned in vir-
tually unlimited amounts. 
The use of McAbs in the biomedical field is well 
established; however McAb production has only recently 
been applied to the field of plant virology (59). Over 
the past four years, plant virologists have utilized McAbs 
to improve already existing, well-established immunologi-
cal techniques including diagnosis of viral infection (32, 
92), virus strain differentiation (14), demonstration of 
serological relationships (31), and quantitation of viral 
antigens (58). In addition, techniques unique to McAb 
methodology have been developed including virus purifica-
tion by affinity chromotography (30), epitope specific 
neutralization of virus infectivity (60), and molecular 
analysis of coat protein epitopes (153). The use of 
hybridoma technology provides a powerful research tool for 
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the plant virologist; however, certain limitations have 
been encountered. 
McAbs, as all antibody molecules, are heterospecific 
and may react with greater affinity with antigens other 
than th~ otiginal immunogen (10, 19). Heterospecificity 
may occur between closely related or completely unrelated 
antigens. This type of cross-reactivity is indicative of 
a shared conformational or sequential epitope recognized 
by the McAb. Heterospecificty is usually not observed 
simply because the investigator does not look for the 
unrelated cross-reacting antigen. 
McAbs, being a homogenous population, contain only a 
subset of the properties observed with conventional 
polyclonal antisera. Therefore, McAbs cannot necessarily 
be utilized in assays developed with polyclonal antisera. 
Many McAbs are specific for epitopes which are inacces-
sible on the antigen surface. This reduces the pos-
sibility of antibody-antigen cross-linking and thus 
precipitation formation (72). Therefore, McAbs which 
possess these characteristics cannot be used in assays 
which require visible immunoprecipitation, such as Ouch-
terlony double diffusion and microprecipitin tests. Addi-
tional problems have been associated with immunoassays 
such as ELISA and RIA which utilize antibody labelled with 
enzyme or radioisotope, respectively. Many McAbs are 
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extremely labile and labelling may result in loss of 
biological activity or alteration of specificity (60). 
Furthermore, loss of activity may occur when an unstable 
McAb is bound to a solid-phase support (148). To obtain a 
McAb with the desired characteristics, one should screen 
the McAb producing hybridomas utilizing techniques for 
which the McAb will ultimately be intended. 
20 
MATERIALS AND METHODS 
General Methods 
Distilled and deionized water 
Reagent grade 1 distilled-deionized water (ddH20) was 
used in the preparation of all media and buffers and as 
the final rinse for all glassware and plasticware. This 
was obtained by passing distilled water through a Super-Q 
Ultra Pure Water System (Millipore Corp., Bedford, MA) 
containing activated charcoal, which removes organic ions, 
and a mixed bed ion-exchange resin, for removal of inor-
ganic ions. 
Phosphate buffer 
A solution of 0.05M NaKP04, pH 7.6, was used as a 
diluent when grinding MDMV infected tissue for virus 
inoculum. This buffer was prepared as follows: 
Solution A: 
Na2HP04 7H20 13.4 g 
ddH20 up to 1000 ml 
Solution B: 
KH2P04 3.4 g 
ddH20 up to 500 ml 
Adjust solution A to pH 7.6 by titration with solution B. 
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Phosphate buffered saline (PBS) 
A solution of O.lM PBS, pH 7.2, was used as a general 
diluent for virus, immunochemicals, and cell line 
preparations . This solution was prepared as follows: 
Solution A: 
Na2HP04 7H20 26 . 8 g 
NaCl 8.5 g 
ddH20 up to 1000 ml 
Solution B: 
NaH2P04 H20 6.9 g 
NaCl 4.3 g 
ddH20 up to 500 ml 
Adjust solution A to pH 7.2 by titration with solution B. 
Virus propagation 
MDMV-A (8, 9) and MDMV-B (ATCC-PV53; 54) were 
propagated and purified from Sorghum sudanese Piper 
(Stapf), cv. Trudan 5 (Northrup King Corp., Minneapolis, 
MN) and Zea mays L. cv. Golden Bantam, respectively. 
Inoculation of propagation hosts was performed by grinding 
approximately 0.5 g of infected, symptomatic, tissue in a 
mortar and pestle (Coors Brewery, Boulder, CO) with 10-15 
ml of phosphate buffer. Carborundom (600 mesh)-dusted 
leaves were mechanically inoculated with infected sap by 
gently rubbing with the thumb and forefinger dipped in 
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inoculum. To compensate for increased transpiration 
through wounds, plants were watered immediately following 
inoculation. 
Purification of MDMV 
Concentration and purification of virus was performed 
by a modification of the procedure of Langenberg (82). 
All centrifugations were performed at 4 C with rotors 
cooled to the same temperature. A typical purification 
consisted of 1500 g of infected tissue. The reagents used 
for virus purification were prepared as described below. 
Grinding buffer (Q.lM ammonium citrate,£!:! .§_.Q, 
containing 1_.Q% polyvinylpyrrolidone and Q.~% l-
mercaptoethanol) Infected plant tissue was triturated 
in this buffer during the initial purification steps . 
Addition of 2-mercaptoethanol inhibits oxidation and 
subsequent activation of host viral inhibitors. This 
buffer was prepared as follows: 
(NH4)2HC6H507 
ddH20 up to 
22.62 g 
1 1 iter 
Adjust the pH to 6. 0 with solid KOH, then add: 
polyvinylpyrrolidone (Sigma #PVP-40) 10.0 g 
2-mercaptoethanol (Sigma #M-6250) 5.0 ml 
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Extraction buffer (Q.lM ammonium citrate,£!! &.Q, 
containing Q.lM ~-mercaptoethanol) This buffer was 
used to resuspend the polyethylene glycol (PEG) 
precipitated virus and prepare the sucrose cushion. The 
buffer consisted of: 
22.62 g 
ddH20 up to 1 liter 
Adjust the pH to 6.0 with solid KOH, then add: 
2-mercaptoethanol 7.0 ml 
Suspension buffer (Q._!!1 ammonium citrate, £!! &.Q) 
This buffer was used in the final purification steps and 
is the purified virus storage buffer. The buffer con-
sisted of: 
(NH4)2HC5H507 
ddH20 up to 
The pH was adjusted to 6.0 with solid KOH. 
22.62 g 
1 liter 
Purification procedure Young, symptomatic leaves 
on the propagation host were harvested approximately 10-14 
days following inoculation. Infected tissue was 
triturated in a commercial sized Waring blender with an 
equal volume (w/v) of grinding buffer. Ice was added 
occasionally to reduce the temperature of the grinding 
mixture. Following maceration, the sap was expressed 
through two layers of cheesecloth. Foam, which may be 
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present on the collected sap, was allowed to settle for 
20-30 min. The crude sap was blended with carbon 
tetrachloride to a concentration of 5 % (v/v) for 10 sec 
and was immediately centrifuged at 6000 x g for 10 min. 
This process clarifies the crude sap, as carbon 
tetrachloride denatures and precipitates a variety of 
plant cell constituents. Following centrifugation, the 
supernatant was filtered through glass wool to eliminate 
residual carbontetrachloride. 
Virus was precipitated from the clarified sap by 
addition of 0.25% (v/v) Triton X-100 (Sigma #T-6878) and 
6.0% (w/v) polyethylene glycol (PEG), molecular weight= 
6000. The mixture was stirred for 30 min at room tempera-
ture and then centrifuged at 9200 x g for 20 min. The 
supernatant was discarded and the pellets, containing 
virus, were resuspended in extraction buffer and 
centrifuged at 8000 x g for 10 min. The supernatant was 
collected and the pellets were extracted 2-3 times with 
extraction buffer. The initial supernatant and each 
extraction supernatant were combined. 
Virus was further separated from plant constituents 
by centrifugation at 68,000 x g for 1.5 hr through 8.0 ml 
of 20% sucrose (w/v; Sigma #S-9378) in 25 x 89 Ultra Clear 
centrifuge tubes (Beckman Instruments Inc., #344058). The 
supernatant, containing plant contaminants, was discarded 
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and the viral pellets were resuspended overnight in 
suspension buffer. Remaining plant constituents were 
removed by low-speed centrifugation at 6000 x g for 20 
min. The supernatant was collected and the pellets were 
extracted once or twice with suspension buffer. The 
initial supernatant and each extraction supernatant were 
combined . 
Virus was further purified through linear 10-40 % 
sucrose gradients in an SW 27 swinging bucket rotor 
(Beckman) centrifuged at 22,000 x g for 2 hr. The 
gradients were fractionated from the bottom using an ISCO 
Density Gradient Fractionator model 640. Virus containing 
zones were detected spectrophotometrically at A254 and 
collected. Pellets obtained in the centrifuge tubes, as a 
result of virus aggregation, were resuspended in suspen-
sion buffer and centrifuged through another sucrose 
gradient. 
Sucrose in the collected virus peaks was removed by 
overnight dialysis against suspension buffer. The 
dialysate was concentrated by ultracentrifugation for 2 hr 
at 65,000 x g. The purified virus was resuspended in 2-4 
ml of suspension buffer and concentrations were estimated 
spectrophotometrically by using A0.1% = 2. 4 (112). 260 
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Glassware and plasticware preparation 
Before use, all glassware and plasticware (except 
that which was used for virus purification) was washed 
three times with distilled water and then rinsed briefly 
with 10% hydrochloric acid in ddH20. This was followed by 
three more rinses with distilled water and one final rinse 
with ddH20. Use of this procedure was most critical when 
preparing tissue culture media and reagents. 
Production of Monoclonal Antibody-Secreting Hybridomas 
The technique used for the production of monoclonal 
antibodies is a modification of the procedure described by 
Van Deusen and Whetstone (149). Significant modifications 
including duration of PEG exposure and pH of fusion media, 
have recently been reported by Lane (81) and Westerwoudt 
(157), respectively . The specialized reagents and media 
are described below. 
Dulbecco'~ modified eagle medium (DMEM) 
Dulbecco's modified eagle medium was used as the 
basic nutritive medium. Modifications of this medium were 
prepared for specialized uses. The basic nutritive medium 
consisted of: 
DMEM high glucose (Gibco 
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Laboratories, Grand Island, NY; 
#430-2100) 1 package (10 g) 
NaHC03 
HEPES (Sigma #H-3375) 
ddH20 up to 
15.0 g 
29.9 g 
5 liters 
The pH was adjusted to 7.2-7.4 with NaOH saturated ddH20 
and filter sterilized through a sterile 0.22 um x 90 mm 
Zetapore Membrane Filter (AMF Cuno, Meriden, CT; #NM090-
01-020SP). The medium was stored in 500 ml volumes at 4 
C. Serum added to the medium was a mixture of 2 parts 
horse serum (Gibco #230-6050) and 1 part calf serum (Gibco 
#230-6170). Two bottles of DMEM containing 10% and 20% 
serum were used to prepare specialized media described 
below. All specialized media was stored at 4 C unless 
stated otherwise. 
lOOX 1-glutamine 
A lOOX solution of L-glutamine was prepared by dis-
solving 2.92 g of L-glutamine (Sigma #G-3126) into 100 ml 
of ddH20. The L-glutamine solution was filter sterilized 
through a sterile 0.2 um syringe filter (Schleicher and 
Schull, Dessel, W. Germany; #462-200) and stored at -20 C 
in 1.0 ml aliquots. L-glutamine was a required nutrient 
used in the preparation of all cell growth media . 
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Regular growth medium (DMEM-~) 
DMEM-R, used for the growth of all established cell 
lines, was prepared by adding 1.0 ml of lOOX L-glutamine 
to 100 ml of DMEM containing 10% serum. DMEM-R not used 
within two weeks was discarded. 
~-azaguanine medium (DMEM-~-aza) 
8-azaguanine (8-aza) medium was used to eliminate 
Sp2/0 mutants resistant to aminopterin (149). The 8-aza 
solution was prepared by placing 2.0 mg of 8-aza (Sigma 
#A-8526) into 1 liter of ddH20. The 8-aza was disolved on 
a magnetic stirrer at 37 C overnight. DMEM-8-aza was 
prepared as described for DMEM; however, the 8-aza solu-
tion was used in place of ddH20 and the other reagents 
were scaled down to 1 liter. DMEM-8-aza was used to 
continuously culture Sp2/0 cells, except 1 week after 
thawing and 10 days prior to performing cell fusions. 
Conditioned medium (CM) 
DMEM-R, which has turned orange-yellow due to Sp2/0 
growth, is termed conditioned medium. CM is thought to 
contain certain growth factors which alleviate the need 
for growth supplements or feeder cell-layers (136). After 
2-3 days growth in DMEM-R, Sp2/0 cells are centrifuged in 
a clinical centrifuge (International Clinical Centrifuges, 
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Boston, MA) at 225 x g for 10 min and discarded. If not 
used immediately for media preparations, the supernatant 
(CM) was stored at -20 C in 100 ml volumes . 
Cell viability stain 
Trypan blue (Allied Chemical, New York, NY; #508) was 
used as a cell viability stain when performing all cell 
counts. The stain was prepared just before use by dilut-
ing a stock solution of 4.0 % (w/v) trypan blue in PBS 
1:50 with PBS. The membranes of dead cells were permeable 
to trypan blue and thus stained dark blue. Viable cells 
remained colorless. 
Polyethylene glycol 1000 (PEG-1000) 
Polyethylene glycol (molecular weight = 1000 daltons; 
Hazelton #59-90739) solution was prepared at least 2 hr 
prior to performing a fusion by solubilizing 2.25 g of 
PEG-1000 into 2.7 ml of PBS at 37 C. PEG-1000 was util-
ized as the chemical fusogen during cell fusion proce-
dures. 
Fusion medium (DMEM-£.) 
Cell fusion medium was used to dilute fused cells 
after incubation with the fusogen PEG-1000. DMEM-F was 
prepared by adjusting the pH of serum-free DMEM to 8.0 
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with 1.0N NaOH in ddH20. The medium was filter sterilized 
through a 0.2 um syringe filter and stored in 25 ml 
volumes. Use of this high pH fusion medium significantly 
increases the number of successful hybridomas produced 
during the fusion procedure (157). 
Hypoxanthine-aminopterin-thymidine medium (DMEM-HAT) 
Hypoxanthine-aminopterin-thymidine (HAT) medium was 
used to select successful mouse spleen and Sp2/0 cell 
fusions. Sp2/0 cells lack the hypoxanthine-guanine 
phosphoribosyltransferase (HGPRT) gene and are thus sus-
ceptable to aminopterin. In successful mouse spleen and 
Sp2/0 cell fusions (hybridomas), the HGPRT gene is sup-
plied by the spleen cell. Therefore, the hybridomas can 
ultilize supplied hypoxanthine and thymidine in an alter-
nate, salvage-pathway for nucleotide synthesis (36) . 
DMEM-HAT was prepared by adding 1.0 ml of sterile lOOX HAT 
solution (Hazelton-Dutchland Inc., Denver, CO; #59-77076) 
to 100 ml of filtered DMEM-CT. The lOOX HAT solution was 
stored at -20 C in 1. 0 ml volumes. 
Hypoxanthine-thymidine medium (DMEM-HT) 
Hypoxanthine-thymidine (HT) medium was used to wean 
the hybridomas off HAT medium. The presence of exogenous 
hypoxanthine and thymidine is neccessary for hybridoma 
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growth until aminopterin is diluted to tolerable levels by 
successive feedings or cloning (36). DMEM-HT and lOOX HT 
solution (Hazelton #59-57076) were prepared and stored as 
described for DMEM-HAT using lOOX HT solution in place of 
lOOX HAT solution. 
Cloning and thawing medium (DMEM-CT) 
Cloning and thawing medium was used in both cell 
cloning and thawing procedures. DMEM-CT was prepared by 
adding 50 ml of CM to 50 ml of DMEM containing 20% serum, 
and adding 1.0 ml of lOOX L-glutamine. The medium was 
filter sterilized through a 0.2 um syringe filter prior to 
use. DMEM-CT ultilizes the additional growth factors 
supplied by CM to promote cell growth under stressful 
conditions. 
Cell freezing medium 
This medium was used to freeze all valuable cell 
lines. Cell freezing medium was prepared by adding 10 ml 
of Dimethyl Sulfoxide (DMSO; Sigma #D-2650) to 90 ml of 
serum . 
Growth and maintenance of the ~IQ cell line 
The non-immunoglobulin producing myeloma cell line 
Sp2/0-Ag 14 (Sp2/0) was first generated by Schulman et al. 
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(127). The Sp2/0 cell line utilized in these experiments 
was generously donated by R.A. Van Deusen (National 
Veterinary Services Laboritories, Ames, IA). The cells 
were grown in stationary suspension in Corning 25 cm2 
tissue culture flasks (T-flasks; Allied Fisher Scientific, 
Chicago, IL; #10-126-30) with loosened caps kept at 37 C 
with humidified 5.0 % C02 in air. The cells were main-
tained in continuous culture by passing at a 1:20 dilution 
in nutritive medium every 3 days. DMEM-8-aza was utilized 
as the nutritive medium with the following exceptions: 1) 
cells were fed continuously with DMEM-R 10 days prior to 
performing a fusion, 2) DMEM-R was used when generating 
CM, and 3) DMEM-CT was utilized during cell thawing proce-
dures. 
Maintenance of healthy, exponentially dividing, Sp2/0 
cells free of mutations was essential for the generation 
of stable hybridomas. To reduce the possibility of cell 
line mutations, as a result of long-term continuous cul-
ture, the following modification of the procedure of 
Reading (115) was used. Sp2/0 cells were dispensed into 
several cryotubes and frozen at -100 C as described on pp. 
39-40. After 30 days of continuous culture, all Sp2/0 
cell cultures were discarded and a fresh culture was 
established from frozen stocks. This cycle was repeated 
every 30 days and frozen stocks were replaced every 6 
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months by freezing cells from a recently thawed and ex-
panded culture. 
Immunization of mice with MDMV 
All immunizations were performed on female mice of 
the Balb/C strain (Jackson Labs, Bar Harbor, ME). 
Purified MDMV was diluted to 50 ug in 0.1 ml of PBS (final 
concentration 1.0 mg/ml). The diluted virus was mixed 1:1 
(v/v) with Freunds 1 complete adjuvant (Sigma #F-5881) and 
emulsified by repeated passage of the mixture through an 
18 gauge needle. The entire volume was injected into a 
single mouse by the intraperitoneal route (IP). Five to 
eight weeks later the mice were given a second IP injec-
tion with 25 ug of virus emulsified in Freunds' complete 
adjuvant as described. Approximately 2 weeks later, the 
mice were hyperimmunized by intravenous administration of 
25 ug of virus in PBS. The mice were sacrificed three days 
following hyperimunization. 
Cell fusion protocol 
Hyperimmunized mice were exsanguinated via cardiac 
puncture and the serum was collected by centrifugation of 
the clotted blood using a Sure-sep II (General Diagnostics 
Division of Warmer-Lambert Co., Morris Plains, NJ; 
#33709). The sera was stored at -20 C and later titered 
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by ELISA. The sacrificed mouse was soaked in a 400 ml 
beaker with 300 ml of 70% ethanol (ETOH) in ddH20 and 
positioned on the sterile surface of a Biogard laminar 
flow hood (Baker Co. Inc., Biddeford, MA) with the right 
flank down. The spleen was aseptically removed and placed 
in a Corning 60 x 15 mm tissue culture dish (Fisher #08-
772-21) with 2.0 ml of DMEM. The spleen was perfused by 
injection with 10.0 ml of DMEM using a sterile 10 ml 
syringe barrel (Becton-Dickinson Division, Rutherford, NJ; 
#5604) equipped with a sterile 26 gauge needle (B-D 
#5625). The spleen was discarded and the spleen cell 
suspension was placed into a Corning 50 ml polypropylene 
centrifuge tube (Fisher #05-538-55). Cell aggregates were 
disrupted by passing the suspension through a 10 ml pipet 
several times. An estimate of viable spleen cells was 
obtained by diluting 0.1 ml of spleen cell suspension 1:50 
in cell viability stain. Viable cells were counted in a 
hemacytometer (AO Instrument Co., Buffalo, NY) and cell 
numbers were calculated: total cells counted X 1.0 x 105 X 
volume of cell suspension. Generally, the suspension 
contained 7.0-8.0 x 107 viable spleen cells. 
Viable Sp2/0 cells were added to the spleen cell 
suspension at a ratio of 1:2 (Sp2/0:spleen cells) and the 
cells were centrifuged in a clinical centrifuge at 225 x g 
for 10 min. The supernatant was discarded and the cell 
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pellet was immediately resuspended by gently swirling the 
centrifuge tube. 
Note: The following fusion procedure involves use of 
the highly toxic PEG-1000 as a fusogen; therefore, careful 
timing of each step was critical. 
Over a 15 sec period, 1.0 ml of solubilized PEG-1000 
sterilized through a 0.2 um syringe filter was slowly 
added to the cell suspension. Two ml of DMEM-F was added 
immediately over a period of 30 sec and the fusion mixture 
was swirled gently. At this point, 10.0 ml of DMEM-F was 
added over a 60 sec period, the tube was swirled gently, 
and the mixture was incubated at 37 C for 5 min. 
Following incubation the cells were centrifuged in a 
clinical centrifuge at 225 x g for 10 min. The super-
natant was discarded and the cells were gently resuspended 
in 1.0 ml of DMEM-HAT. Once fully resuspended, the 
suspension was diluted with DMEM-HAT to 5.0 x 105 Sp2/0 
cells/ml. Using a sawed-off 10 ml pipet (sawed-off pipets 
were prepared by scoring and snapping off the tip of a 
long-nose glass 10 ml pipet and fire-polishing the end), 
the cell suspension was dispensed at 0.2 ml / well in Corn-
ing 96-well tissue culture plates (Fisher #08-757-155). 
The cell cultures were incubated at 37 C with humidified 
5.0 % C02 in air. 
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Growth and maintenance of hybridomas 
The culture plates were examined daily for media 
color changes due to contamination. On the 3rd and 7th 
days post-fusion, the cells were fed by aspirating the 
spent medium and adding 0.2-0.3 ml/well of DMEM-HAT. 
After 3 days, hybridomas were observed with a Nikon in-
verted microscope (Frank E. Fryer Co. Inc., Carpen-
tersville, IL; model 64453); they appeared as refractive 
colonies of up to 20 cells. An average of 8 hybridoma 
colonies/well were detected in each of the approximate 600 
wells cultured. 
Hybridomas were assayed for specific antibody produc-
tion by indirect ELISA no later than 10 days post-fusion; 
all positive hybridomas were cloned immediately. Wester-
woudt et al. (158) found that on day 14 post-fusion only 
35 %, of the original positives assayed on day 10, were 
still positive. Therefore, it is critical to assay and 
clone positive hybridomas before day 14 post-fusion. The 
process of weaning the hybridomas off HAT was performed 
during the cloning and expansion procedures. 
Hybridoma cloning and expansion 
The cloning procedure utilized is a modification of 
the limiting-dilution procedure presented by Galfre and 
Milstein (36). Significant modifications which alleviate 
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the need for time-consuming scale-up procedures were 
developed in our laboratory by R. L. Mernaugh, F. E. 
Jones, and C. W. Kaspar. 
Specific antibody-producing hybridomas were 
thoroughly resuspended by mixing the contents of a single 
well with a Falcon cotton-plugged 2.0 ml serological 
pipete (B-D #7507) equipped with a rubber propipette. One 
drop (approximately 50 ul) of the cell suspension was 
transferred to a sterile Falcon 13 X 100 mm tube (B-D 
#2027) containing 5.0 ml of DMEM-HT . The remainder of the 
suspension (approximately 0.2 ml) was transferred to a 
single well of a Corning 24-well tissue culture plate 
(Fisher #08-757-156) containing 1.0 ml of DMEM-HT. The 
tube was inverted several times and 1 drop of cell suspen-
sion was transferred to a second tube containing 5. 0 ml of 
DMEM-HT . The second tube was inverted several times and 
the contents of this tube were dispensed at 0.1 ml/well 
into 48 wells of a 96-well tissue culture plate . The 
plates were incubated at 37 C with humidified 5.0 % C02 in 
air . Three to four days later, the 96-well tissue culture 
plates were examined for wells containing single colonies 
using a low-power (40X) inverted microscope. Cells in 24-
well tissue culture plates were fed by aspirating the 
spent media and adding 1.5 ml of DMEM-HT. When the cells 
had grown to confluency on the bottom of the well (ap-
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proximately 3 days), the contents of that well were 
frozen. 
After 7 days, 0.1 ml of DMEM-CT was added to each 
well of the 96-well tissue culture plate. Three days 
later, wells containing single colonies were assayed for 
specific antibody production by indirect ELISA. An 
antibody-producing colony from a single well was 
thoroughly resuspended, transferred, and cloned in DMEM-CT 
as described previously. The cloning cycle was repeated 
until all wells containing single colonies were positive 
for specific antibody production. If no positive colonies 
were obtained after the first cloning cycle, the 
hybridomas' frozen counterpart was thawed and cloned in 
DMEM-CT. Completely cloned cell lines, producing specific 
McAb, were immediately expanded and frozen. 
Cell lines were expanded as follows. A McAb-
producing colony from a single well was thoroughly 
resuspended and transferred to a single well of a 24-well 
tissue culture plate with 1.0 ml of DMEM-R. Three days 
later, the cells were fed by aspirating off the spent 
media and replacing with 2.0 ml of DMEM-R. Once the cells 
had grown to confluency on the bottom of the well, they 
were resuspended and the entire volume was transferred to 
a 25 cm2 T-flask with 8.0 ml of DMEM-R. The cells were 
grown to a density of approximately 6.0 x 105 cells/ml and 
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then frozen. These cell lines were also maintained in 
continuous culture by passing them at a 1:5 dilution in 
DMEM-R and injected into mice for ascites fluid produc-
tion. 
Cell line freezing procedure 
Sp2/0 cells, hybridomas, and McAb-producing cell 
lines were frozen at -100 C for short-term storage (up to 
6 months) or in liquid nitrogen (-196 C) for long term 
storage (6 months to 1 yr). McAb-producing cell lines 
were frozen immediately following the final cloning cycle, 
as continuous culture for more than 14 days may result in 
loss of antibody production. 
Cells to be frozen were cultured in 25 cm2 T-flasks 
with 10.0 ml of DMEM-R. When the cell density was ap-
proximately 6.0 x 105 cells/ml (media color orange-
yellow), the cells were centrifuged in a clinical 
centrifuge at 225 x g for 10 min. The supernatant, which 
contains a low level (10-50 ug/ml) of specific McAb, was 
decanted and stored at -20 C in a Corning sterile 50 ml 
polypropylene centrifuge tube. The pellet was gently 
resuspended in 5.0 ml of cell frezing medium and dispensed 
into 5 Nunc 1.2 ml cryotubes (Vangard International, 
Neptune, NJ; #366656) at approximately 1.2 x 106 
cells/tube. 
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Cells cultured in 24-well tissue culture plates were 
also frozen to eliminate time-consuming cell expansion 
procedures. When the cells had grown to confluency on the 
bottom of the well, the entire volume of spent media was 
aspirated. The cells were resuspended in 1. 5 ml of cell 
freezing medium and transferred to a 1.2 ml cryotube. 
The cryotubes were placed into Nunc transport con-
tainers (Vangard #241) and packaged in a 20 X 20 X 6 cm 
styrofoam freezing chamber such that temperature reduction 
approximates 1 C/min . The freezing chamber was placed at 
-100 C in a Queue Cryostar cryogenic freezer (Lab Research 
Products, Lincoln, NE) overnight. The following day the 
cryotubes were removed from the freezing chamber and 
either placed directly into liquid nitrogen or placed back 
at -100 C. 
Cell line thawing procedure 
The following procedure was used to establish a 
culture from frozen stocks. The cryotube, containing the 
culture of interest, was removed from the freezer or 
liquid nitrogen and placed immediately into a 37 C in-
cubator to thaw. Once thawed, the cryotube was inverted 
several times to fully resuspend the cells. The cell 
suspension was transferred to a Corning sterile 15 ml 
polypropylene centrifuge tube (Fisher #05-538-530) with 
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10.0 ml of DMEM and centrifuged at 225 x g for 10 min. 
The supernatant was discarded and the pellet was gently 
resuspended in 2.0 ml of DMEM-CT. The cell suspension was 
dispensed at 1.0 ml/well into 2 wells of a 24-well tissue 
culture plate and incubated at 37 C with humidified 5.0 % 
C02 in air . 
Three days later the cells were fed by aspirating the 
spent media and replacing with 2.0 ml of DMEM-CT. When 
the cells had grown to confluency on the bottom of the 
well they were transferred to 25 cm2 T-flasks and fed with 
DMEM-R as described. 
Ascitic fluid production 
Hybridoma cells injected into compatible mice induce 
formation of ascites tumours and production of ascites 
fluid containing high levels (up to 10 mg/ml) of specific 
antibody. The parameters affecting ascitic fluid produc-
tion have been optimized (136). 
Specific McAb-producing hybridomas were maintained in 
continuous culture as described. When the cells grew to 
an approximate density of 6 x 105 cells/ml (one T-flask 
with 10 ml of cells was sufficient to inject 3 mice), they 
were collected by centrifugation at 225 x g for 10 min. 
The supernatant was decanted and stored at -20 C as 
described . The hybridoma pellet was gently resuspended 
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and washed twice with PBS warmed to 37 C. The final 
pellet was resuspended in sufficient PBS to give 1.0 x 107 
cells/ml. Pristane-primed male mice of the Balb/C strain 
(mice were pristane-primed by injection, IP, with 0.5 ml 
of 2, 6, 10, 14, tetramethylpentadecane (pristane; Sigma 
#T-7640) two weeks previous) were injected, IP, with 0.2 
ml of hybridoma suspension (approximately 2.0 x 106 
cells/mouse). 
The mice were observed daily for abdominal swelling. 
When swelling was pronounced (7-10 days), the tumour was 
drained by inserting a sterile 18 gauge, 3.8 cm needle (B-
D #5196) into the peritoneal cavity and allowing the 
ascitic fluid to drain into a Corning sterile 50 ml 
polypropylene centrifuge tube. The mice were usually 
tapped 2-3 days later and then sacrificed. The ascitic 
fluid was centrifuged at 1000 x g for 10 min to remove 
cells. The supernatant was assayed for specific McAb by 
indirect ELISA and immediately stored at -20 C in 5.0 ml 
aliquots . Using this procedure, each mouse produces 10-20 
ml of ascitic fluid and usually survives 14-16 days after 
injection with hybridomas. 
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Indirect enzyme-linked immunosorbant assay (ELISA) for the 
detection of MDMV specific antibody 
A successful fusion usually results in the culture of 
500-600 wells containing hybridomas. The loss or inac-
tivation of antibody producing chromosomes frequently 
yields both non-producing and producing hybridomas in the 
same well (158). Goding (42) has shown that antibody 
production may take up to 30-50 % of the cellular energy; 
therefore, hybridomas not producing antibody may divide 
more rapidly and overgrow the useful hybridomas . The loss 
of chromosomes and the danger of overgrowth decreases with 
time (158). Thus a simple, rapid, and sensitive assay 
must be incorporated to detect desirable hybridomas and 
allow cloning shortly after fusion. 
Modifications of the indirect ELISA described by 
Voller et al. (156) are utilized for the rapid, routine, 
detection of specific antibody. This ELISA was designed 
such that positive results could be easily visual i zed or 
quantitated spectrophotometrically. The buffers and 
reagents used were prepared as follows: 
BLOTTO (~.Q % non-fat dry milk ..i.!! PBS) 
BLOTTO was used to block any protein binding s i tes remain-
ing after coating microtitration plates with antigen. 
BLOTTO is very inexpensive to prepare, but cannot be 
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utilized if a peroxidase enzyme system is incorporated as 
non-fat dry milk contains exogenous peroxidase activity. 
BLOTTO consisted of: 
Non-fat dry milk (Hy-Vee Food 
Stores, Ames, IA) 
Antifoam A emulsion (Sigma 
#A-5758) 
O.lM PBS, pH 7.2 up to 
10.0 g 
70 ul 
200 ml 
BLOTTO was prepared fresh daily and 200 ml was sufficient 
to block 3 96-well microtitration plates. 
Wash buffer (Q.OlM PBS, B!! Z·i• containing Q.05 % 
Tween-20) Wash buffer was used to remove unbound reac-
tants and reduce non-specific reactions. This buffer was 
prepared fresh daily and prepared as a 5X concentrate if 
an assay required use of more than three microtitration 
plates. The wash buffer and 5X concentrate were prepared 
as follows: 
IX 5X 
NaCl 42.5 g 212.5 g 
KH2P04 1.0 g 5.0 g 
KCl 1.0 g 5.0 g 
Na2HP04 5.8 g 29.0 g 
Tween-20 (Sigma #P-1379) 2.5 ml 12.5 ml 
ddH20 up to 5 1 iters 5 1 iters 
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Substrate buffer (_!Q.Q % diethanolamine j.I1_ ddHzQ, £!! 
~.Q) Substrate buffer was used to dilute the alkaline 
phosphatase substrate, p-nitrophenyl phosphate (p-NPP). 
The p-NPP was obtained in tablet form (5 mg/tablet; Sigma 
#104-105) and diluted to 1.0 mg/ml in 5.0 ml of substrate 
buffer immediately before use. Conveniently, one p-NPP 
tablet provided sufficient substrate for one 96-well 
microtitration plate. The substrate buffer was stored at 
4 C and the p-NPP tablets were stored at -20 C until use. 
Substrate buffer was prepared as follows: 
Diethanolamine (Sigma #0-8885) 
MgCl 6H20 
ddH20 up to 
50.0 ml 
50.0 mg 
500 ml 
Stop solution (3N NaOH) To quantitate results 
spectrophotometrically it was neccessary to terminate the 
enzyme-substrate reaction. This was accomplished by 
adding 50 ul of 3N NaOH/well. 
Indirect ELISA procedure Unless stated otherwise, 
each step of the ELISA was incubated in a humidified 
chamber for 1 hr at room temperature or overnight at 4 C. 
Wells of a Nunc certified Immuno I 96-well 
microtitration plate (Vangard #4-39454) were coated with 
50 ul of purified MDMV/well diluted to 5.0 ug/ml in 5.0 ml 
of PBS. Following incubation, the plate was washed by 
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first discarding the MDMV solution and then submerging the 
plate into a 2 liter beaker filled with wash buffer. When 
all the wells had filled, the plate was removed and the 
wash buffer was sharply 11 fl icked 11 from the wells of the 
plate. This was repeated 4 times in rapid succession and 
the plate was incubated for 5 min with wash buffer follow-
ing the last cycle. After the final wash cycle, the 
entire contents of the beaker was discarded and replaced 
with fresh wash buffer. The plate was tapped dry on paper 
towels and unbound protein sites were blocked by com-
pletely filling all the wells with BLOTTO. The plate was 
incubated and washed as described. The plate could then 
be used immediately or stored at 4 C up to 4 days without 
loss of specificity or sensitivity. 
Specific antibody was bound to immobilized MDMV by 
adding (50 ul/well) hybridoma culture media which had 
supported cell growth for 3 or more days (media color 
orange-yellow). Typical controls added to each plate 
included hyperimmune mouse serum diluted 1:1000 in PBS 
(positive control), normal mouse serum diluted 1:1000 in 
PBS, and CM (negative controls). The plate was incubated 
and washed 3 times as described. Hybridomas were assayed 
for the production of antibody classes immunoglobulin G 
(lgG) and immunoglobulin M (lgM). This was performed by 
adding (50 ul/well), a mixture of alkaline phosphatase 
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conjugated rabbit anti-mouse IgG (Sigma #A-1902) and 
alkaline phosphatase conjugated goat anti-mouse IgM (Sigma 
#A-7784), both diluted 1:1000 in wash buffer with 1.0 % 
fraction V bovine serum albumin (BSA; Sigma #A-4503). The 
plate was incubated and washed 3 times as described. 
Then, 50 ul of diluted substrate was added to each well 
and color development was allowed to procede for 30-60 min 
before the addition of stop solution. 
For quantitation experiments, A410 of each well was 
measured in a Dynatech Minireader II (Dynatech 
Laboratories Inc . , Alexandria, VA; #011-930-0500) . The 
color development of each well could also be determined 
visually . Positive wells were distinguished as various 
intensities of yellow when compared to colorless negative 
controls . Positive hybridomas were cloned and expanded as 
described. 
Immunoglobulin class and subclass determination 
For protein A purification purposes, it was necessary 
to determine the Ig class and subclass secreted by cloned 
cell lines. The IgM class cannot be purified using 
protein A chromatography and purification of the IgG class 
expresses subclass varability (43). 
The McAb Ig class was determined by a modification of 
the indirect ELISA procedure described previously. Each 
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cloned McAb producing cell line was represented by two 
wells on a microtitration plate previously coated with 
homologous virus and blocked with BLOTTO. To one of these 
wells was added 50 ul of alkaline phosphatase conjugated 
rabbit anti-mouse IgG diluted 1:1000 in wash buffer con-
taining 1.0 % BSA. The same dilution of alkaline phos-
phatase conjugated goat anti-mouse IgM was added to the 
other well. The McAb class was determined by observing 
which lg class specific conjugate reacted with the McAb 
following addition of substrate. 
lg subclass determination was only performed with IgG 
secreting cell lines. All neccessary immunochemicals and 
reagents were purchased as a MonoAb-ID EIA Kit (Zymed 
Laboratories Inc., San Francisco, CA; #90-6550). The 
procedure was performed in a Nunc 96-well microtitration 
plate as described by the subclass kit manufacturer. 
Positive wells were blue-green when compared to the color-
less negative controls. The McAb subclass was determined 
by observing which IgG subclass specific rabbit anti-mouse 
reacted with the McAb following addition of substrate. 
On occasion the substrate solution supplied with the 
kit was inactive and was thus replaced by the following 
peroxidase substrate solution. 
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ABTS substrate (g, g, azino-.Qi-[].-ethylbenzthiazoline 
sulfonic acid]) 
Solution A (0.05M citric acid, pH 4.0): 
HOCCOOH(CH2COOH)2 H20 1.05 g 
ddH20 up to 
Adjust the pH to 4.0 with 1. 0N NaOH. 
Solution B (40 mM ABTS): 
ABTS (Sigma #A-1888) 
solution A 
Substrate mixture: 
solution A 
solution B 
3.0 % H202 in ddH20 
100 ml 
45 mg 
2.0 ml 
5.0 ml 
20 ul 
25 ul 
Each solution was stored at 4 C in separate brown bottles 
and the substrate mixture was prepared fresh daily. Old 
solutions react non-specifically with proteins and were 
thus replaced every 2 months. 
Polyacrylamide Gel Electrophoresis (PAGE) of Viral 
Polypeptides 
Preparation of viral proteins for SOS-PAGE 
To obtain several protein polypeptides of various 
molecular weights, the viral coat protein was denatured 
50 
and proteolytically diges t ed. Initially, purified virus 
was treated with an excess of 2-mercaptoethanol and SOS . 
The 2-mercaptoethanol reduces disulfide bonds and the SOS 
binds to regions of the protein to cause disruption of 
intramolecular protein associations. The denatured 
protein subunits were then proteolytically cleaved into 
fragments of various molecular weights. The amount of 
proteolytic enzyme and the digestion period were optimized 
to produce a wide range of fragment mobilities during SOS-
PAGE. The buffers used for this procedure are described 
below. 
Dialysis buffer (Q.125M Tris-HCl, £!! ]_.§_, containing 
Q._1% _g_-mercaptoethanol) This reducing buffer was used 
to dialyze purified virus preparations prior to SOS 
degradation . Dialysis buffer consisted of: 
Trizma HCl (Sigma #T-3253) 
Trizma base (Sigma #T1503) or 
Tham 
2-mercaptoethanol 
60.6 g 
13.9 g 
4.0 ml 
4 1 iters 
If neccessary, adjust pH to 7.6 with 1.0N NaOH or 1.0N 
HCl. 
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Degradation buffer (Q.125M Tris-HCl, Bl!& · ~· contain-
l.!!.9. l.Q% SOS and l.Q% _g_-mercaptoethanol) This buffer 
was used to degrade and solubilize viral proteins prior to 
proteolytic digestion. Degradation buffer consisted of : 
Trizma HCl 1.76 g 
Trizma base or Tham 
Laural sulfate (SOS; Sigma 
#L-5750) 
2-mercaptoethanol 
ddH20 up to 
Adjust pH to 6.8 with 1.0N HCl. 
0.168 g 
1.0 g 
1.0 g 
100 ml 
Sample buffer In addition to bromophenol blue used 
as a tracking dye, sample buffer also contained an excess 
of 2-mercaptoethanol and SOS to maintain the denatured 
state of the disrupted protein fragments. This buffer was 
prepared as follows: 
Tris base (Bio-Rad #161-0716) 
SOS (Bio-Rad #161-0301) 
2-mercaptoethanol 
Glycerol 
Bromophenol blue 
0. 76 g 
1.0 g 
2.0 ml 
15 . 0 ml 
1 mg 
100 ml 
Adjust the pH to 6. 8 with 1.0N HCl and store at r oom 
tempera tu re. 
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Procedure for viral protein preparation Purified 
MDMV was adjusted to a concentration of approximately 2.0 
mg/ml with dialysis buffer and dialyzed overnight at 4 C 
against two changes of dialysis buffer. The dialyzed 
virus was adjusted to a concentration of 1.0 mg/ml with 
dialysis buffer. An equal volume of degradation buffer 
was added and the viral proteins were degraded by placing 
the mixture in a boiling water bath for 20 min. Once 
degraded, the solubilized proteins were immediately cooled 
on ice and stored at 4 C until use. 
The enzyme used for the digestion of both MDMV-A and 
MDMV-B viral proteins was a protease isolated from 
Staphylococcus aureus, strain V8 (V8 protease; Sigma #P-
8400). During optimization procedures, the lypholyzed V8 
protease preparation was reconstituted to 2.0, 1.0, and 
0.5 mg/ml in dialysis buffer. To each 100 ul of viral 
protein to be digested, 20 ul of V8 protease was added. 
The digestion mixtures were incubated at 37 C for 2, 4, or 
6 hr. Following incubation, the digestion mixtures were 
placed in a boiling water bath for 10 min and then im-
mediately cooled on ice. The protein fragments were 
analyzed by SOS-PAGE using a Bio-Rad mini-gel as 
described. Further digestions were performed using the 
optimized V8 protease concentration and digestion time. 
Prior to electrophoresis, digested protein samples 
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were diluted (usually 1:1) to the desired concentration 
with sample buffer. To solubilize and maintain the dena-
tured state of the proteins, each diluted sample was 
placed in a boiling water bath for 2 min and cooled on ice 
before application to the gel. 
Discontinuous SOS-PAGE (disc-SOS-PAGE) 
Separation of digested MDMV protein fragments was 
accomplished using the disc-SOS-PAGE system described by 
Laemmli (80) with stacking and resolving gels of 4.0 % and 
15.0 % acrylamide, respectively. Disc-SOS-PAGE effi-
ciently stacks and separates protein fragments by 
electrophoresis through use of a high pH glycine electrode 
buffer and a low pH Tris buffered stacking gel. Briefly, 
dilute samples are added to the upper electrode buffer 
chamber. When an electrical potential is applied to the 
system, current flow induces the flow of glycine ions in 
the electrode buffer. The protein fragments and the 
glycine ions migrate into the low pH stacking gel. Titra-
tion at low pH produces an increased negative charge on 
the polypeptides and a reduced negative charge on the 
glycine ions. As a result, the protein fragments have a 
greater mobility than the glycine ions and thus accumulate 
ahead of the glycine front. Furthermore, chloride ions in 
the Tris buffered stacking gel, carrying a negative 
54 
charge, migrate even faster than the protein fragments. 
This results in the concentration and stacking of dif-
ferent molecular weight proteins perpendicular to the 
current flow. 
Continued current flow and migration into the high pH 
resolving gel results in a higher glycine ion negative 
charge and a reduced protein negative charge. Therefore, 
each, pre-stacked, protein fragment migrates through the 
resolving gel as a function of its unique charge and 
shape. The specialized buffers required to perform Disc 
SOS-PAGE are described below. 
Acrylamide solution Acrylamide solution contains 
the acrylamide monomer and the cross-linker N, N1 -
methylene-bis-acrylamide (bis-acrylamide). The monomer 
and cross-linker remain relatively stable when mixed; 
however, when the free-radical initiator ammonium persul-
fate (APS) is added along with the catalyst N, N, N1 , N1 -
tetramethylethylenediamine (TEMED), polymerization 
occurs. A 30 % stock acrylamide solution was prepared as 
follows: 
Acrylamide (Bio-Rad #161-0101) 30.0 g 
Bis-acrylamide (Bio-Rad 
#161-0201) 0.8 g 
ddH20 up to 100 ml 
Acrylamide solution was stored at 4 C in the dark for a 
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maximum of 30 days. 
Resolving~ buffer (l.5M Tris-HCl, Qt!~-~) This 
high pH buffer was used to prepare the 15.0 % resolving 
gel. Resolving gel buffer consisted of: 
Tris base 18.17 g 
Disodium ethylenediamine tetra-
acetate (EDTA) 0.15 g 
ddH20 up to 100 ml 
Adjust pH to 8.8 with 1.0N HCL and store at 4 C. 
Resolving~ preparation (_12.Q % acrylamide, Q.375M 
The resolving gel separates protein 
fragments which have been concentrated and stacked in the 
stacking gel. All buffers were warmed to room temperature 
prior to use. The monomer volume required to pour two 
mini-gel or two 16 cm gel sandwiches was 10.0 and 60.0 ml, 
respectively. The resolving gel was prepared as follows: 
Total Monomer 10. 0 ml 60.0 ml 
--- ---
Resolving gel buffer 2.5 ml 15.0 ml 
Acrylamide solution 5.0 ml 30.0 ml 
10 % (w/ v) SOS in ddH20 0.1 ml 0.6 ml 
ddH20 2.35 ml 14.1 ml 
The mixture was degassed for 15 min at room temperature 
and used immediately. 
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Stacking~ buffer (Q.5M Tris-HCl, B.!:! &_.~) This 
low pH buffer increases the negative charge on proteins 
and thus facilitates protein fragment stacking in the 4.0 
% gel. Stacking gel buffer consisted of: 
Tris base 6.06 g 
100 ml 
Adjust pH to 6.8 with concentrated HCl and store at 4 C. 
Stacking~ preparation (_1.Q % acrylamide, Q.125M 
The combination of low pH and low 
acrylamide concentration facilitates charge stacking of 
protein fragments in the stacking gel. All buffers were 
warmed to room temperature prior to use. The monomer 
volume required to pour two mini-gel or two 16 cm gel 
sandwiches was 10.0 and 20.0 ml , respectively. The stack-
ing gel was prepared as follows: 
Total Monomer 10.0 ml 20.0 ml 
--- ---
Stacking gel buffer 2.5 ml 5.0 ml 
Acrylamide solution 1. 3 ml 2. 6 ml 
10 % (w/v) SOS in ddH20 0.1 ml 0. 1 ml 
ddH20 6. 1 ml 12.2 ml 
The mixtu re was degassed for 15 min at room temperature 
and used immediately. 
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Electrode buffer (Q.025M Tris-HCl, £!:! ~.].) This 
buffer contains a high concentration of glycine ions to 
allow current flow from the upper buffer chamber through 
the gel to the lower buffer chamber. Electrode buffer 
consisted of: 
Tris base 
Glycine (Sigma #G-7126) 
SDS 
Adjust pH to 8.3 with concentrated HCl. 
Gel fixative and staining solution 
12.1 g 
57.6 g 
4.0 g 
4 1 iters 
The addition of 
methanol to this solution prevents gel shrinkage and thus 
distortion. In addition, acetic acid fixes the gel during 
staining procedures. The gel fixative and staining solu-
tion consisted of: 
Methanol 200.0 ml 
Glacial acetic acid 50.0 ml 
Brilliant (Coomassie) blue R 
(Sigma #B-0630) 0.5 g 
ddH20 up to 500 ml 
The gel fixative and destaining solution was saved after 
every use and could be reused several times. 
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Gel destain solution Gel destain solution con-
sisted of: 
Methanol 400.0 ml 
Glacial acetic acid 100.0 ml 
ddH20 up to 1 liter 
Casting and running miniature Disc SDS-polyacrylamide 
~ The Bio-Rad Mini-Protean II slab gel system (#165-
2900) was used to prepare all miniature gels (mini-gel). 
The mini-gel (7 cm X 8 cm X 0.75 mm) could be run 5 times 
faster than conventional 14 cm X 16 cm gels . Thus, the 
mini-gel was utilized almost exclusively to optimize 
enzyme concentrations and digest times, and to observe 
digested preparations before running large samples on the 
14 X 16 gel system. 
The gel sandwich plates and the electrophoresis 
chamber were assembled as described by the manufactures' 
instructions. The resolving gel was poured into one 
sandwich at a time using 5.0 ml of the degassed resolving 
gel preparation. The resolving gel monomer was poured 
into a 10 .0 ml syringe barrel equipped with a 25 gauge 1.6 
cm needle (B-D #5122) placed into a rubber stopper to 
prevent leakage. The acrylamide was polymerized by adding 
2.5 ul of TEMED (final concentration 0.05 %; Bio-Rad #161-
0800) and 25 ul of 10 % APS [final concentration 0.05 %; 
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10 % APS was prepared fresh daily by dissolving 100 mg of 
APS (Bio-Rad #161-0700) in 1. 0 ml of ddH20J. The 
polymerization mixture was swirled momentarily and quickly 
poured through the syringe needle into the gel sandwich to 
a level of 5.0 cm . The resolving gel was immediately 
overlaid with water-saturated butanol using a pasteur 
pipete and bulb and allowed to polymerize for 1 hr. 
Following polymerization, the overlay solution was rinsed 
off by forcing a gentle stream of ddH20 through the spout 
of a wash bottle. The area above the resolving gel was 
blotted dry using Whatman 3MM filter paper. 
As with the resolving gel, only one stacking gel was 
polymerized at a time. A well-forming comb was placed 
into the gel sandwich and tilted slightly to prevent air 
from being trapped under the comb teeth. Five ml of the 
stacking gel monomer were placed into the 10.0 ml syringe 
barrel and polymerized by adding 5.0 ul of TEMED (final 
concentration 0.1 %) and 25 ul of 10 % APS (final con-
centration 0.05 %). The polymerization mixture was 
swirled momentarily and added to completely fill the gel 
sandwich. The comb was properly aligned and the gel was 
allowed to polymerize without overlay solution for 1 hr. 
After polymerization, the comb was slowly removed and the 
wells were rinsed with ddH20. 
The gels were attached to the inner cooling core as 
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described by the manufacturer and the buffer chambers were 
filled with electrode buffer. The samples, diluted in 
sample buffer, were added (20 ul/well) with a 25 ul Hamil-
ton syringe (Hamilton Co., Reno, Nevada). The syringe 
barrel was thoroughly rinsed in ddH20 between samples. 
The polypeptides were separated by electrophoresis from 
the anode (+) to the cathode (-) at 200 volts (constant 
voltage setting) for 45-50 min. 
Separated polypeptides were stained by incubating the 
resolving gel in gel fixative and staining solution 
overnight. The gel was destained the following day with 
several changes of gel destaining solution over a 1-2 hr 
period. At this point, the gel could be stored per-
manently by drying under vacuum onto Whatman 3MM filter 
paper. 
Casting and running conventional Disc SDS-
polyacrylamide ~ The Bio-Rad Protean II slab gel 
system (#165-1802) was used in the preparation of all 14 
cm X 16 cm X 1.5 mm slab gels. Because of their size and 
resolution capabilities these slab gels were utilized to 
separate polypeptides for subsequent immunoblot analysis. 
The gel sandwich plates and the gel chamber were 
assembled as described by the manufacturer. The resolving 
gel was polymerized in one gel sandwich at a time using 
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30.0 ml of the resolving gel preparation. Degassed 
resolving gel monomer was poured into a 50.0 ml syringe 
barrel equipped with an 18 gauge 3.8 cm needle placed in a 
rubber stopper to prevent leakage. The gel was 
polymerized by adding 15 ul of TEMED (final concentration 
0.05 %) and 150 ul of APS (final concentration 0.05 %). 
The polymerization mixture was swirled momentarily and 
poured through the syringe needle into the gel sandwich to 
a level of 11.0 cm. The gel was immediately overlaid with 
water-saturated butanol and allowed to polymerize for 1 
hr. When the gel was completely polymerized, the overlay-
ing solution was rinsed off and the surface of the resolv-
ing gel was blotted dry as described. 
As with the resolving gel, one stacking gel was 
polymerized at a time using 10.0 ml of stacking gel 
preparation. The degassed stacking gel monomer was placed 
into the 50.0 ml syringe barrel and polymerized by adding 
10 ul of TEMED (final concentration 0.1 %) and 50 ul of 10 
% APS (final concentration 0.05 %). The polymerization 
mixture was swirled momentarily and poured through the 
syringe needle to a level of 2.0 cm. A well-forming comb 
was not used; rather, the gel was immediately overlaid 
with water-saturated butanol and allowed to polymeri ze for 
1 hr. After rinsing off the overlay buffer, the ge 1 was 
used immediately or stored at room temperature unt i l the 
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following day. If the gel was stored overnight, ap-
proximately 10.0 ml of stacking gel buffer, diluted 1:5 in 
ddH20, was placed on top of each gel to prevent dehydra-
tion. 
A 1.0 ml sample of digested virus was diluted 1:1 
with sample buffer and prepared for electrophoresis as 
described. Both buffer chambers on the electrophoresis 
cell were filled with electrode buffer and the entire 
sample was evenly applied to the stacking gel surface 
using a 10.0 ml syringe barrel equipped with an 18 gauge 
3.8 cm needle. The sample became evenly distributed over 
the entire stacking gel surface within 30 sec. 
Electrophoresis through the stacking gel was initially at 
150 volts (approximately 1 hr) with 2 gels. The power wa s 
increased to 250 volts as the sample migrated through the 
resolving gel. Electrophoresis was terminated when the 
bromophenol blue tracking dye eluted off the bottom of the 
resolving gel (total of 5-6 hr). At this point, port ions 
of the resolving gel were fixed and stained as descri bed 
or the entire resolving gel was transferred to a nit rocel-
lulose membrane for use in immunoblot procedures. 
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Immunoblot Analysis Of Monoclonal Antibodies 
Electrophoretic separation of protein fragments and 
subsequent analysis of the polypeptides on nitrocellulose 
blots was utilized to demonstrate epitope specificity of 
antibody from cloned McAb-producing cell lines. Briefly, 
viral proteins were enzymatically digested and the poly-
peptides were separated by discontinuous polyacrylamide 
gel electrophoresis (PAGE) in the presence of sodium-
dodecyl sulfate (SOS) as described by Laemmli (80). The 
polypeptides were then electrophoretically transferred 
from the gel electropherogram and non-covalently bound to 
a nitrocellulose solid-phase as first described by Towbin 
et al. (147) and recently reviewed by Towbin and Gordon 
(146). McAbs which specifically bound to the immobilized 
protein fragments could then be detected using enzyme 
immunoassay techniques. Differences in protein binding 
patterns were interpreted as suggesting different epitope 
specificity exhibited by the McAbs. 
Transfer of proteins from~ electropherogram to 
nitrocellulose membrane ("western blotting") 
Electrophoretic elution of polypeptides from a gel 
electropherogram to a solid-phase nitrocellulose (NC) 
membrane results in a high resolution copy of the original 
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gel electropherogram. Individual NC bound polypeptides 
can be specifically identified using enzyme immunoassay or 
a non-specific amido black stain can be used for 
visualization of all polypeptides. The buffers and 
reagents used during the transfer and total protein stain-
ing procedures are described below. 
Transfer buffer (Q.025M Tris-HCL, Q!! ~.]) This 
buffer contains methanol and SOS to facilitate the elution 
and binding of protein fragments to the NC support. 
Transfer buffer consists of: 
Tris base 
Glycine 
Methanol 
ddH20 up to 
Adjust the pH to 8.3 with concentrated HCl. 
12.1 g 
57.7 g 
1 1 iter 
4 1 iters 
Nitrocellulose staining solution A solution of 
amido black was used for total protein staining on the NC 
blot. The staining solution consisted of: 
Naphthol blue black (amido 
black; Sigma #N-3005) 
Methanol 
Glacial acetic acid 
0.1 g 
45.0 ml 
10.0 ml 
100 ml 
Nitrocellulose staining solution was saved after every use 
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and reused several times. 
Nitrocellulose destaining solution 
destaining solution consisted of: 
Methanol 
Glacial acetic acid 
ddH20 up to 
Nitrocellulose 
90.0 ml 
2.0 ml 
100 ml 
Protein transfer and nitrocellulose staining 
procedures Electro-elution of protein fragments from 
the gel electropherogram and subsequent binding to the NC 
membrane was perfomed in a home-made transfer cell, of a 
design similar to the commercially available cell from 
Bio-Rad. Plastic gloves were worn to prevent non-specific 
protein contamination of the NC membrane during handling. 
The transfer assembly was prepared in a baking dish 
filled to approximately 3.0 cm with transfer buffer. A 
plastic support was placed in the baking dish and layered 
with a Scotch-brite pad, 3 sheets of Whatman 3MM filter 
paper, the resolving gel, and a sheet of type HAHY 0.45 um 
NC membrane (Millipore #HAHY-000-10). The NC was care-
fully positioned over the resolving gel and air bubbles 
were gently removed. The transfer assembly was completed 
by reversing the stack beginning with the filter paper. 
If two gels were transferred simultaneously, the stacking 
procedure was repeated after the last sheet of filter 
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paper. The transfer assembly was held together with 2 
rubber bands, one at each end, and placed into the trans-
fer cell with the nitrocellulose facing the anode (+) and 
the gel facing the cathode (-). 
The cell was filled with transfer buffer and protein 
transfer was performed at 100 mA (constant mA setting) for 
18 hr. When the transfer was complete, excess NC was 
removed with a razor blade and the gel was stained to 
confirm that transfer of the protein fragments was 
complete. The nitrocellulose was cut lengthwise into 1.0 
cm wide strips. 
During electrophoresis, samples have a propensity to 
form "smiles" (band patterns curve upward) at both sides 
of the gel. These smiles are transferred to the NC and 
thus render the outside NC strips of little use for im-
munoblot analysis. Therefore, these strips were stained 
for total protein in nitrocellulose staining solution for 
5-10 min and immediately destained for 2-3 min in several 
changes of nitrocellulose destaining solution. NC 
membranes are not stable in acidic methanol and should be 
removed when completely destained. The remainder of the 
NC strips have identical protein patterns and were util-
ized for immunoblot analysis. 
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Immunoblot of nitrocellulose bound polypeptides 
The technique of immunoblotting combines the high 
resolution of PAGE with the sensitivity of enzyme 
immunoassays. Nitrocellulose serves as the solid phase, 
such that the immunoblot can be performed as an indirect 
ELISA with longer incubation and wash steps, and an 
enzyme-substrate reaction which produces an insoluble 
product. The buffers and specialized substrate neccessary 
to perform an immunoblot are described below. 
Blocking buffer (Q.05M carbonate, £.!! _2.§_, containing 
3 % BSA) Blocking buffer was used to quench all unbound 
sites on the NC membrane. This buffer consisted of: 
Na2C03 0.16 g 
NaHC03 0.29 g 
BSA 3.0 g 
ddH20 up to 100 ml 
If neccessary, adjust the pH to 9.6 with 1.0N NaOH or 1.0N 
HCl. 
Nitrocellulose wash buffer (Q.05M Tris-HCL, £.!! l·i• 
containing Q.05 % Tween-20) This buffer was used to 
remove unbound reactants from the nit roce 11 u lose and 
reduce background reactions. The nitrocellulose wash 
buffer consisted of: 
Tri zma HCl 13.22 
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Trizma base or Tham 
NaCl 
Tween-20 
ddH20 up to 
1. 94 g 
17.0 g 
1. 0 ml 
2 liters 
If neccessary, adjust the pH to 7.4 with 1.0N NaOH or 1.0N 
HCl. 
AP z_.~ buffer (Q.lM Tris-HCl, Qt! z_.~, containing Q.05 
% Triton !-100) This buffer was used to wash the NC 
membrane and supply neccessary divalent cations for the 
enzyme-substrate reaction. Wash steps using AP 7.5 buffer 
are performed quickly to prevent elution of specific 
proteins by Triton X-100 from the blot. This buffer 
consisted of: 
Trizma HCl 25.4 g 
Trizma base or Tham 4. 72 g 
NaCl 11. 7 g 
MgCl2 6H20 0.81 g 
Triton X-100 (Sigma #T-6878) 1. 0 ml 
ddH20 up to 2 liters 
If neccessary, adjust the pH to 7.5 with 1.0N NaOH or 1.0N 
HCl. 
This buffer 
was used as the final prepatory wash before addition of 
substrate. AP 9.5 buffer contains divalent cations nee-
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cessary for the enzyme-substrate reaction. This buffer 
consisted of: 
Trizma HCl 
Trizma base or Tham 
NaCl 
MgCl2 6H20 
ddH20 up to 
Adjust the pH to 9.5 with saturated NaOH. 
Nitrocellulose substrate reagent 
3.04 g 
21.88 g 
11.7 g 
2.03 g 
2 liters 
The NC substrate 
reagent for alkaline phosphatase was prepared as described 
by Leary et al. (85). The slightly yellow substrate 
produces a dark purple-blue, insoluble precipitate, which 
binds to regions of NC where alkaline phosphatase con-
jugate has been specifically immobilized. 
To prepare 15.0 ml of the substrate reagent, 5.0 mg 
of nitro blue tetrazolium (NBT; Sigma #N-6876) was placed 
into a 1.5 ml micro-centrifuge tube (USA/Scientific Plas-
tics Inc., Ocala, FL; #USA-505) with 1.5 ml of AP 9.5 
buffer and vortexed for 1-2 min. NBT not solubilized was 
removed by centrifugation for 60 sec in a Beckman 
microfuge B. The supernatant was decanted into a 50 ml 
beaker containing 10.0 ml of AP 9.5 buffer warmed to 37 
C. The NBT pellet was extracted twice with 1.5 ml of AP 
9.5 buffer; each time the supernatant was decanted into 
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the 50 ml beaker. The centrifuge tube was rinsed with 0.5 
ml of AP 9.5 buffer and added to the NBT solution. In a 
separate micro-cenrifuge tube, 2.5 mg of 5-bromo-4-chloro-
3-indolyl phosphate (BCIP; Sigma #B-8503) was added to 50 
ul of N, N-dimethyl formamide. The BCIP was dissolved by 
briefly vortexing the solution, which was then added to 
the NBT solution dropwise with gentle mixing. The NBT-
BCIP substrate reagent was prepared fresh daily and stored 
at 37 C in the dark until use. 
Color stop (Q.OlM Tris-HCl, ..P!! .z_.~, containing lmM 
EDTA) Color stop was used to terminate color develop-
ment during the enzyme-substrate reaction. This buffer 
contains the chelating agent EDTA which sequesters 
divalent cations neccessary for enzyme function. A lOX 
color stop concentrate was prepared as follows: 
Trizma HCl 1.27 g 
Trizma base or Tham 0.24 g 
Disodium EDTA 0.37 g 
ddH20 up to 100 ml 
If neccessary, adjust the pH to 7.5 with 1.0N NaOH or 1.0N 
HCl. The lOX concentrate was diluted in ddH20 prior to 
use. 
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Immunoblot procedure The 1.0 cm NC strips, 
prepared previously, were placed into a baking dish with 
blocking buffer and incubated at room temperature on a 
rocker platform for 2-3 hr. The NC membranes were washed 
on a rocker platform with 3 changes of NC wash buffer over 
a 30 min period. The NC strips were then placed into 
separate Seal-a-Meal bags (Dazey Corporation, Industrial 
Park, KS) with culture media (collected during cell freez-
ing procedures), containing specific McAb, diluted 1:5 in 
NC wash buffer. One bag contained CM as a negative 
control. The bags were sealed and incubated overnight as 
described. 
The following day, the NC strips were removed from 
the bags and washed with NC wash buffer as described. 
Immobilized McAb was further reacted with a mixture of 
alkaline phosphatase conjugated rabbit anti-mouse IgG and 
alkaline phosphatase conjugated goat anti-mouse IgM, both 
diluted 1:1000 in NC wash buffer with 1.0 % BSA. The 
strips were incubated in a baking dish for 1 hr and washed 
as described. After the final wash step, the NC strips 
were quickly washed 3 times (3-5 min/wash) with AP 7.5 
buffer. The strips were then washed with 3 changes of AP 
9.5 buffer over a 30 min period. The strips were trans-
ferred to a separate baking dish and the NC substrate 
reagent was added. Color development was allowed to 
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proceed for 15-20 min before adding the color stop 
solution. At this point, the NC strips were photographed 
for a permanent record or stored in the dark with color 
stop solution. 
Isolation of Monoclonal Antibody From Ascitic Fluid 
Purification of mouse monoclonal lg!1 from ascitic fluid 
The purification of IgM is a difficult and time-
consuming process. The most common method utilized is 
precipitation of antibody with 40 % saturated ammonium 
sulfate, followed by gel filtration. However, this proce-
dure may form IgG aggregates which could emerge with IgM 
during gel filtration (43). 
The purification method described below is a 
modification of the original procedure described by Garvey 
et al. (39). Briefly, ascitic fluid containing specific 
IgM was added to a solution of 2.0 % boric acid. The 
combination of low pH, low ionic strength, and the propen-
sity of boric acid to complex with carbohydrates results 
in the specific precipitation of IgM. Contaminating low 
molecular weight proteins are separated from the IgM 
molecules by sepharose gel filtration. Buffers utilized 
during the purification of IgM are described below. 
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2.0 % Boric acid A 2.0 % boric acid solution 
prepared in ddH20 was used to specifically precipitate IgM 
molecules from ascitic fluid. The pH of the solution was 
approximately 4.0 and was never adjusted. Boric acid 
solution was prepared immediately before use. 
This buffer, used to 
solubilize the IgM pellet following precipitation with 
boric acid and as sepharose gel filtration elution buffer, 
was prepared as follows: 
Tri zma HCL 
Trizma base or Tham 
NaCl 
35.52 g 
21. 2 g 
34.0 g 
4 1 iters 
If neccessary, adjust the pH to 8.0 with 1.0N NaOH or 1.0N 
HCl. 
l.9!:1 purification procedure Approximately 10.0 ml 
of ascitic fluid containing specific IgM was thawed and 
the lipid layer was removed using a pasteur pipete 
equipped with a bulb . The ascitic fluid was added drop-
wise to 200 ml of boric acid (ascitic fluid:boric acid 
ratio 1:20) with gentle stirring. The mixture was in-
cubated at room temperature for 30 min and the 
precipitated antibody was collected by centrifugati on at 
800 x g for 10 min. The clear supernatant was di scar ded 
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resuspended in 1.0 ml of O.lM Tris-HCl saline, pH 8.0. 
The solubilized antibody was dialyzed overnight against 
two changes of O.lM Tris-HCl saline, pH 8.0, at 4 C. The 
pro t ein content of the dialysate was estimated using E0.1% 280 
= 1.4. 
Sepharose CL-6B beads (Pharmacia Inc., Pisactaway, 
NJ; #17-0160-01) were poured into a 58 cm X 1.5 cm i.d. 
column as described by the manufacturer. Before use, a 
10.0 mg/ml solution of Blue Dextran 2000 (molecular weight 
2,000 kd; Pharmacia # 17-0360-01) was chromatographed to 
determine the void volume and visually assess the 
homogenity of the packed column . 
The IgM preparation was diluted 1:1 with glycerol and 
applied directly to the column bed with a pasteur pipette 
equipped with a bulb. The sample was chromatographed 
using O.lM Tris-HCl saline, pH 8.0, as the elution buffer 
at a flow rate of 0.25 ml/min . Following elution of the 
35.0 ml void volume, 1.0 ml fractions were collected until 
A280 returned to zero. Each fraction was assayed for the 
presence of specific IgM by indirect ELISA and positive 
fractions were pooled in 5.0 ml volumes. The protein 
content was estimated using E~3J % = 1.4 and the pooled 
fractions were stored at -20 C until use. 
75 
Purification of mouse monoclonal _!_g§ from ascitic fluid 
The purification of mouse monoclonal IgG has been 
greatly simplified through the use of protein A affinity 
chromotagraphy. Protein A is isolated from the bacterium 
Staphlococcus aureus and has a characteristic property of 
binding IgG with high affinity and specificity. However, 
one should recognize that there is considerable variation 
in the binding and stability among the different sub-
classes of IgG (43). The buffer used to collect the eluted 
fractions is described below. 
This buffer was used to 
increase the pH of fractions containing IgG collected from 
the protein A column. The Tris buffer was prepared as 
follows: 
Trizma HCl 
Trizma base or Tham 
ddH20 up to 
1. 52 g 
10.94 g 
1 1 iter 
If neccessary adjust the pH to 9.0 with 1.0N NaOH or 1.0N 
HCl. 
1...9.Q purification procedure Purification of 
monoclonal IgG was performed with a Bio-Rad Affi-gel 
protein A MAPS column (#153-6153) using procedures and 
buffers provided by the manufacture. Briefly, 5.0 ml of 
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ascitic fluid containing specific IgG was thawed, diluted 
1:1 with binding buffer (Bio-Rad #153-6160), and applied 
directly to the column with a pasteur pipette. Con-
taminating proteins were eluted from the column with 15 
bed volumes of binding buffer. Affinity bound IgG was 
eluted from the column with 5 bed volumes of a low pH 
elution buffer (Bio-Rad #153-6160). The eluted IgG was 
detected spectrophotmetrically at A280 and collected in 
1.0 ml aliquots into a test tube containing 2.0 ml of O.lM 
Tris-HCl, pH 9.0. The final pH of the eluted IgG and Tris 
solution was approximately 8.0. Each fraction was assayed 
for the presence of specific IgG by indirect ELISA and 
positive fractions were pooled in 5.0 ml aliquots. The 
protein content was estimated using E~8B% = 1.4 and the 
pooled fractions were stored at -20 C until use. 
Development and Use of a Monoclonal Antibody Based 
Enzyme-Linked Immunosorbent Assay 
ELISA's provide a simple, rapid, and specific method 
for the detection of viral antigens. Traditionally, 
polyclonal antisera, derived from rabbits, has been util-
ized when developing immunological detection assays. 
However, polyclonal antisera contains a heterogenous 
population of antibody molecules which may exhibit cross-
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reactivity with plant sap or antigens closely related to 
the immunogen. Although some McAbs may also cross-react 
with closely related antigens, one can select for 
specificity. 
The ELISA described below was developed based upon 
the concept of a polyclonal double-sandwich-ELISA (ds-
ELISA) as outlined by Clark and Adams (1977). Epitopi-
cally distinct hybridomas (determined by immunoblot 
analysis), secreting antigen specific IgM and secreting 
antigen specific IgG were utilized as capture and second 
antibodies, respectively. 
Optimization of the double sandwich enzyme-linked im-
munosorbent assay (ds-ELISA) 
The ds-ELISA described below was designed with an IgM 
capture antibody and an IgG second antibody to avoid 
conjugation of the second antibody with enzyme or 
radioisotopes. Monoclonal IgM was utilized as the capture 
antibody because IgM has greater avidity for specific 
antigen and a greater affinity towards plastics than IgG 
(140). Furthermore, the commercially available rabbit 
anti-mouse IgG conjugate does not cross-react with mouse 
IgM, but goat anti-mouse IgM will cross-react with mouse 
IgG. 
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Each step of the ds-ELISA which involved the use of 
immunochemicals was optimized. The optimal concentration 
of a particular immunochemical is that concentration which 
produces the highest positive response (all reactants 
present) and the lowest negative response (all reactants 
present except virus). This relationship is represented 
by P/N and is calculated by dividing the positive response 
by the negative response. The buffers and reagents util-
ized throughout the optimization procedures have been 
described previously under the indirect ELISA procedure. 
The additional buffer neccessary to perform the ds-ELISA 
is described below. 
Binding buffer (Q.05M carbonate, £.ti 2 . .§) This high 
pH buffer was used to non-covalently bind mouse monoclonal 
IgM to wells of a microtitration plate. Binding buffer 
was prepared as follows: 
Na2C03 0.16 g 
0.29 g 
100 ml 
If neccessary, adjust the pH to 9.6 with 1.0N NaOH or 1.0N 
HCl . 
Optimization procedure Unless stated otherwise, 
each step of the ds-ELISA was incubated in a humidified 
chamber for 1 hr at room temperature or overnight at 4 C. 
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The plate wash procedure was performed as described for 
indirect ELISA . 
The concentration of capture antibody was optimized 
by performing a serial dilution of purified IgM from 1: 100 
to 1:1600 in binding buffer. Each dilution was used to 
coat 8 wells of a 96-well microtitration plate at 50 
ul/well. The plate was incubated and washed as 
described. Unbound protein sites were blocked by com-
pletely filling each well of the microtitration plate with 
BLOTTO. The plate was incubated and washed as described. 
Then, homologous virus, diluted 1.0 ug/ml in PBS, was 
added (50 ul/well) to 4 wells of each capture antibody 
dilution . To the other 4 wells, PBS (50 ul/well) was 
added as a negative control. The plate was incubated and 
washed 3 times. The immobilized virus was further reacted 
with 50 ul/well of purified IgG diluted 1:100 in wash 
buffer. The plate was incubated and washed 3 times. The 
amount of IgG bound to immobilized virus was detected by 
adding 50 ul/well of alkaline phosphatase conjugated 
rabbit anti-mouse IgG diluted 1:1000 in wash buffer with 
1.0 % BSA. The plate was incubated and washed 3 times. 
At this time the colorimetric reaction was initiated by 
adding 50 ul/well of disolved substrate warmed to 37 C. 
The A410 of each well was measured in a plate Minireader 
II. The P/N ratio was calculated from the mean value of 4 
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identical wells. 
The optimal concentration of IgG was determined by 
the same procedure, using the optimized concentration of 
IgM capture antibody. Likewise, the enzyme conjugated 
rabbit anti-mouse IgG was optimized using the calculated 
optimal concentrations of IgM and IgG, with enzyme con-
jugated antibody dilutions of 1:250 to 1:8000 in wash 
buffer with 1.0 % BSA. 
Sample preparation for ~-ELISA 
The detection of virus in infected sap was highly 
dependant upon the grinding buffer utilized during sample 
preparation. Therefore, several grinding buffers were 
tested to determine which would produce the most reliable 
results. 
Approximately 0.5 g of infected or healthy corn 
tissue was macerated in a mortar and pestle with 4.5 ml 
(1:10 dilution) of grinding buffer. The buffers utilized 
to macerate the samples were binding buffer and wash 
buffer, each prepared with and without 2.0 % BSA. The 
plant sap was diluted 1:20 in the respective grinding 
buffer. Each diluted sample was added (50 ul/well) to 4 
wells of a microtitration plate previously coated with 
capture antibody and blocked with BLOTTO. The plate was 
incubated overnight at 4 C and washed 3 times the follow-
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ing day . The assay was completed as described previously 
using optimized concentrations of IgG and enzyme con-
jugated rabbit anti-mouse IgG. The A410 of each well was 
measured and values for the same treatment were averaged. 
P/N ratios were calculated and the grinding buffer which 
produced the highest mean value was used to prepare 
samples for each assay. 
Assay of field isolates for the presence of MDMV 
Virus-infected plants collected from areas of Iowa, 
Ohio, and Nebraska were generously donated to test the 
accuratcy of the McAb based ds-ELISA by John Hill and 
Helen Benner (!SU), Roy Gingery (Ohio Agricultural Re-
search and Development Center), and Stanley Jensen 
(University of Nebraska), respectively. Microtitration 
plates previously coated with capture antibody and blocked 
with BLOTTO were shipped to each out of state cooperator. 
Approximately 0.3-0.5 g of symptomatic tissue was 
macerated in a mortar and pestle with 2.7-4.5 ml of grind-
ing buffer (sap:buffer dilution 1:10) determined as op-
timal for use with the MDMV-A specific ds-ELISA . The 
macerated leaf tissue was removed and 50 ul of plant sap 
was placed into each of 2 wells in the MDMV-A specific ds-
ELISA and 2 wells in the MDMV-B specific ds-ELISA. The 
procedure was repeated with the same sample, grinding the 
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tissue in buffer determined optimal for the MDMV-B 
specific ds-ELISA. The ds-ELISA was performed as 
described and the strain of each MDMV infected plant and 
any cross-reactivity observed was recorded. 
Strain identification of MDMV isolates infecting 
field samples obtained in Iowa was also assessed through 
the inoculation of indicator hosts. Each isolate was 
inoculated to 3 Johnsongrass seedlings as described 
previously. Viral replication within the symptomless 
Johnsongrass host was allowed to progress for 30 days. At 
this time, each Johnsongrass plant was back-inoculated to 
2 Golden Bantam corn seedlings. Symptom development on 
the corn plants was observed and recorded over a 30 day 
period. Original isolates which ellicited symptoms on the 
back-inoculated Golden Bantam were concluded as being 
infected with MDMV-A. Those isolates which did not el-
1 icit symptoms on back-inoculated Golden Bantam could be 
infected with one of several different strains of MDMV 
including MDMV-B. 
Identification of isolates from Ohio, Nebraska, and 
Texas had been established by previous investigators. 
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RESULTS 
Production of Monoclonal Antibodies 
Two fusions were performed, using MDMV-A as one 
inmunogen and MDMV-B as the other. A total of 1187 wells 
in 96-well tissue culture plates were cultured from the 
two fusions. Several hybr i domas were observed after 3 
days and by day 7 post-fusion 1001 or approximately 84 % 
of the wells contained hybridoma colonies. The hybridomas 
were assayed for specific antibody production by indirect 
ELISA using the original immunogen as the coating 
antigen. A total of 746 or approximately 75 % of the 
hybridomas secreted specific antibody. Fifty positive 
hybridomas from the MDMV-A fusion were cloned immediately. 
The cross-reactivity of the MDMV-B pos i tive 
hybridomas was assessed and those which cross-reacted with 
the heterologous MDMV-A strain were di scarded. Only 18 of 
the origina l 260 (7 %) MDMV-B positive hybridomas did not 
cross-react with MDMV-A . These hybridomas were cloned 
immediately. The cloning procedure was very successful as 
26 of the original 50 (52 %) MDMV-A positive hybridomas 
and 11 of the original 18 (61 %) MDMV-B specific 
hybri domas were successfully established and frozen. An 
additional 15 MDMV-A positive hybridomas were successfully 
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established, but subsequently contaminated during the 
freezing procedures; thus the cloning efficiency was 
approximately 71 %. 
Established, McAb-producing, cell lines were given 
three letter designations followed by a roman numeral. 
The first two letters represent the original immunogen 
used to produce and screen the cell line; MA indicating 
that MDMV-A was the immunogen and MB indicating that MDMV-
B was the immunogen. The third and final letter repre-
sents the antibody class secreted by the cell line; M for 
IgM and G for IgG. The three letters are followed by a 
Roman numeral to distinguish cell lines which have the 
same three letter designation. Therefore, a cell line 
which was cloned from the MDMV-B fusion and secretes IgG 
could be designated as MBG III. Table 1 gives a complete 
listing of the established McAb producing cell lines 
derived against MDMV. 
Immunoblot Analysis of Monoclonal Antibodies 
Immunoblot analysis of each McAb-producing cell line 
was utilized to demonstrate epitope specificity of the 
McAbs. I assumed that different immunoblot protein bind-
ing patterns are indicative of epitypically distinct 
McAbs. 
85 
Table 1. Cell line designations, monoclonal antibody 
subclass and light chain secreted, and cross-
reactivity as determined by indirect ELISA 
Cell line IgG subclass Light chain Cross-reactivitya 
MAGI 2a K ++ 
MAGI I 2a K 
MAGI II NTb K NT 
MAMI __ c NT + 
MAMI I NT NT 
MAMI I I NT NT 
MAMIV NT 
MAMV NT 
MAMVI NT 
MAMV I I NT 
MAMVII I NT ++ 
MAMIX NT 
MAMX NT +/-
MAM XI NT +/-
MAMXI I NT 
MAMXI I I NT + 
MAMXIV NT 
MAM XV NT + 
MAMXVI NT NT 
MAMXV I I NT 
MAMXVIII NT 
MAMXIX NT 
MAM XX NT NT 
MAMXXI NT NT 
MAMXXII NT NT 
MAMXXII I NT NT 
MBGI 2p K 
MBGII 2a K 
MBGIII 1 K 
aThe level of cross-reactivity is indicated by: - = 
none, +/- = lower than homologous, + = same as homologous, 
and ++ = greater than homologous. 
bNT = cell line not tested. 
c 
= not applicable to this cell line. 
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Table 1 (Continued) 
Cell line IgG subclass Light chain Cross-reactivity 
MBGIV 
MBGV 
MBGVI 
MBMI 
MBMII 
MBMIII 
MBMIV 
MBMV 
2a 
1 
3 
K 
K 
K 
NT 
NT 
NT 
NT 
NT 
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The enzyme concentration and digestion time utilized 
in the immunoblot procedure were selected to maximize the 
molecular weight range of protein fragments. Mini-gel 
analysis of the V8 protease digested viral protein, shown 
in Figure 1, indicated that an enzyme concentration of 0.5 
mg/ml with a digestion time of 4 hr yielded a sufficient 
number of bands for immunoblot analysis. 
The immunoblot procedure was performed with those 
cell lines which do not cross-react with the heterologous 
strain (Table 1). A total of 6 different protein binding 
patterns were observed. Two produced by the MDMV-A 
specific cell lines; 3 were produced by the MDMV-B 
specific cell lines; and the condition media (CM) negative 
control also resulted in the production of protein bands. 
The protein binding patterns are illustrated in Figure 2 
and the cell lines represented by these binding patterns 
are listed in Table 2. 
Further experiments were perfonned (results not 
presented) to determine the origin of the Cl bands. Using 
molecular weight standards, it was established that all 
three bands have molecular weights greater than the viral 
protein subunit. Therefore, the bands are not of viral 
origin. The Cl binding pattern could be reproduced; 
however, if an immunoblot was performed using V8 protease 
as the antigen. Because a great majority of the cell 
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Figure 1. Optimization of V8 Protease concentration and digestion time. MDMV viral protein was 
digested with 0.5, 1.0 and 2.0 mg/ml of enzyme for 2, 4, or 6, hrs at each dilution. 
Analysis of the digested polypeptides was performed on a Bio-Rad mini-gel as described 
in materials and methods 
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Figure 2. Immunoblot analysis of MDMV-A (Al and A2), MDMV-B (Bl-B3) specific cell lines, and 
conditioned media control (Cl). Viral proteins were digested with V8 Protease and the 
polypeptides were electrophoretically transferred to a nitrocellulose membrane and 
probed with specific McAb's as described in materials and methods. Undigested coat 
protein is represented by ( ~). The McAb secreting cell lines to which the 
immunoblots correspond to are listed in Table 2 
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Table 2. Immunoblot binding patterns exhibited by mono-
clonal antibody producing cell lines 
Ce 11 1 i ne 
MAGI I 
MAM IV 
MAMV 
MAMVII 
MAM IX 
MAMXII 
MAMXIV 
MAMXVI I 
MAMXVIII 
MAMXIX 
MBGI 
MBGII 
MBGIII 
MBGIV 
MBGV 
MBGVI 
MBMI 
MBMII 
MBMIII 
MBMIV 
MBMV 
Immunoblot patterna 
Al 
Al 
Al 
Al 
Cl 
Al 
Al 
Cl 
A2 
Al 
Bl 
Bl 
Bl 
Bl 
Bl 
B3 
Bl 
B3 
B2 
B3 
Bl 
almmunoblot patterns are illustrated in Figure 1. 
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lines recognized the enzyme bands, it is more likely that 
the enzyme inhibits blocking of the nitrocellulose rather 
than specific recognition of the enzyme bands by the 
McAbs. These non-specific enzyme bands can be observed on 
the following blots: 1) upper band of Al, 2) upper three 
bands of A2, and 3) upper two bands of Bl. These bands 
may not be in the same positions as each blot was per-
formed in different experiments. 
Purification of Mouse Monoclonal IgM from Ascitic Fluid 
MDMV-A and MDMV-B specific mouse monoclonal IgM was 
purified from ascitic fluid produced by injection of 
Balb/c mice with the cell lines MAMXVIII and MBMill, 
respectively. The IgM McAb was isolated from ascitic 
fluid by boric acid precipitation and further purified by 
Sepharose gel filtration. 
Boric acid precipitation of 10 ml of ascitic fluid 
yielded approximately 6.5 mg of protein as determined by 
using A~8b% = 1.4. The entire boric acid-treated prepara-
tion was applied to a Sepharose CL-6B gel filtration 
column. The 35 ml void volume was discarded and 1.0 ml 
fractions were collected. The elution profile and the 
specific antibody content of each fraction (as determined 
by indirect ELISA) are depicted in Figure 3. 
94 
Figure 3. Elution profiles and antibody activity of 
Sepharose CL-68 purified monoclonal IgM. A) 
Sepharose elution profile of MDMV-A specific 
IgM (MAMXVIII; ~ ) and MDMV-A specific anti-
body activity of each eluted fraction as 
determined by indirect ELISA (---). B) Seph-
arose elution profile of MDMV-B specific lgM 
(MBMI II; - ) and MDMV-B specific antibody 
activity as determined by indirect ELISA (---) 
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Fractions 4 through 57 containing purified MAMXVIII 
and fractions 10 through 57 containing purified MBMIII 
were each pooled in 5.0 ml aliquots and the protein con-
tent of each aliquot was estimated using A~s6% = 1.4. All 
pooled samples were stored at -20 C until use. Table 3 
and 4 list the protein content of each tube. 
Purification of Mouse Monoclonal lgG from Ascitic Fluid 
MDMV-A specific and MDMV-B specific IgG was purified 
from ascitic fluid produced by the injection of Balb/c 
mice with MAGii and MBGI, respectively. A 5.0 ml ascitic 
fluid sample, containing monoclonal IgG, was diluted 1:1 
with binding buffer and applied to the an Affi-gel Protein 
A column (Bio-Rad). Fractions containing contaminating 
protein were discarded. When the absorbance at 280 nm was 
zero, elution buffer was added directly to the column and 
the 1.0 ml fractions of the IgG peak were collected into 
test tubes containing 2.0 ml of 1.0M Tris-HCl pH 9.0. The 
protein A elution profiles of MAGI! and MBGI are presented 
in Figure 4. Fractions containing specific IgG (as deter-
mined by indirect ELISA) were pooled in 5.0 ml aliquots 
and the protein content of each aliquot was estimated 
using A~8d% = 1.4. The results obtained are shown in 
Tables 5 and 6. 
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Table 3. Protein content of Sepharose CL-68 eluted 
fractions containing MDMV-A specific IgM 
(MAMXVIII) 
Tube Eluted fractionsa A28o Protein content 
1 4-9 0. 783 559 
2 10-15 0.455 325 
3 16-21 0.414 295 
4 22-27 0.440 314 
5 28-34 0.430 307 
6 35-40 0.498 355 
7 41-46 0.459 327 
8 47-52 0. 227 162 
9 53-57 0.139 99 
(ug/ml)b 
aFractions containing MDMV-A specific IgM, as 
determined by indirect ELISA, were pooled and stored in 
5.0 ml volumes. 
bProtein content of each tube was estimated using 
A0.1% = 1 4 280 . . 
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Table 4. Protein content of Sepharose CL-6B eluted 
fractions containing MDMV-B specific lgM 
(MBMIII) 
Tube Eluted fractionsa A280 Protein content 
1 10-15 0.584 417 
2 16-20 0.302 216 
3 21-25 0. 567 405 
4 26-30 0.759 542 
5 31-35 0.553 395 
6 36-40 0. 411 294 
7 41-45 0.415 296 
8 46-50 0.440 314 
9 51-55 0. 377 269 
10 56-57 0.288 206 
(ug/ml)b 
aFractions containing MDMV-B specific IgM, as 
determined by indirect ELISA, were pooled and stored in 
5.0 ml volumes. 
bProtein content of each tube was estimated using 
A0.1% = 1 4 280 .. 
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Figure 4. Elution profiles of MDMV-A specific (MAGI!; A) 
and MDMV-B specific (MBGI; B) protein A purified 
monoclonal IgG. Arrow indicates point of IgG 
elution with elution buffer 
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Table 5. Protein content of Protein A purified fractions 
containing MDMV-A specific IgG (MAGI I) 
Tube A280 Protein content {mg/ml)a 
1 0.495 0.354 
2 2.082 1. 490 
3 1.800 1.290 
4 1. 789 1.280 
5 1.113 0. 795 
6 0.213 0.152 
7 0.086 0.061 
8 0.038 0.027 
9 0.023 0.016 
10 0.028 0.020 
11 0.014 0.010 
aProtein content of each tube was estimated using 
A0.1% = 1 4 280 .. 
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Table 6. Protein content of Protein A purified fractions 
containing MDMV-B specific IgG (MBGI) 
Tube A280 Protein content (ug/ml)a 
1 0.259 185 
2 0.600 429 
3 0.606 433 
4 0.424 303 
5 0.231 165 
6 0.094 67 
7 0.048 34 
8 0.021 15 
9 0.017 12 
10 0.005 4 
11 0.004 3 
12 0.004 3 
13 0.004 3 
aProtein content of each tube was estimated using 
A0.1% = 1 4 280 . . 
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Optimization of Monoclonal Antibody Based ds-ELISA 
The concentrations of capture antibody, second an-
tibody, and enzyme conjugated-antibody were optimized for 
the specific detection of MDMV-A and MDMV-B. Dilutions of 
each reagent were prepared and utilized in the ds-ELISA as 
described. The A410 of each well was measured and the P/N 
ratios calculated for capture antibody, second antibody, 
and enzyme conjugated antibody are expressed graphically 
in Figures 5, 6, and 7, respectively. 
Results indicate that the optimal dilutions of cap-
ture antibody (MAMXVIII), second antibody (MAGii), and 
enzyme conjugated antibody for the specific detection of 
MDMV-A are 1:800, 1:200, and 1:2000, respectively. These 
dilutions correspond to prot ein concentrations of 0.699, 
7.45, and 0.450 ug/ml, respectively. The optimal dilu-
tions of capture antibody (MBMIII), second antibody 
(MBG I), and enzyme conjugated antibody for the specific 
det ect ion of MDMV-B are 1:1600 (highest dilution tested), 
1:400, and 1:2000, respectively. These dilutions cor-
respond to protein concentrations of 0.260, 1.07, and 
0.450 ug/ml, respectively. 
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Figure 5. Determination of the optimal capture antibody 
dilution for the MDMV-A specific ds-ELISA (0-0) 
and the MDMV-B specific ds-ELISA (~). 
Purified monoclonal lgM (MAMXVIII and MBMill, 
respectively) was diluted from 1:100 to 1:1600 
and utilized in the ds-ELISA as described in 
materials and methods. The A410 in the presence 
(P) and absence (N) of virus was measured. P/N 
ratios were calculated and plotted. Data points 
are the mean values of duplicate experiments 
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Figure 6. Determination of the optimal second antibody 
dilution for the MDMV-A specific ds-ELISA ([]-[]) 
and the MDMV-B specific ds-ELISA (~). 
Purified monoclonal IgG (MAGI! and MBGI, 
respectively} was diluted from 1:100 to 1:1600 
and utilized in the ds-ELISA as described in 
materials and methods. The A410 in the presence 
(P) and· absence (N) of virus was measured. P/N 
ratios were calculated and plotted. Data points 
are the mean values of duplicate experiments 
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Figure 7. Determination of the optimal enzyme conjugated 
antibody dilution for the MDMV-A specific 
ds-ELISA (0-0) and the MDMV-B specific 
ds-ELISA (~). Commercially available 
alkaline phosphatase conjugated rabbit anti-
mouse IgG antibody (Sigma A-1902) was diluted 
from 1:250 to 1:4000 and utilized in the ds-
ELISA as described in materials and methods. 
The A410 in the presence (P) and absence 
(N) of virus was measured. P/N ratios were 
calculated and plotted. Data points are the 
mean values of duplicate experiments 
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Sensitivity of Optimized ds-ELISA Using Purified Virus 
The sensitivity of each ds-ELISA was determined with 
dilutions of purified homologous virus from 1000 ng/ml (50 
ng/well) to 1.0 ng/ml (50 pg/well). In addition, non-
specific detection of the heterologous virus was assessed 
for each ds-ELISA using dilutions of purified heterologous 
virus from 10,000 ng/ml (500 ng/well) to 10 ng/ml (500 
pg/well). A reaction was considered positive if the mean 
A410 was greater than 0.10. 
Using optimized conditions, the detection sensitivity 
of the MDMV-A specific ds-ELISA was between 400 and 800 
pg/well or 8 and 16 ng/ml (Figure 8). In addition, no 
cross-reactivity was observed with the heterologous strain 
MDMV-B. The detection sensitivity of the optimized MDMV-B 
specific ds-ELISA was 1.6 ng/well or 32 ng/ml (Figure 9) 
and no cross-reactivity was observed with the heterologous 
strain MDMV-A. 
Sample Preparation for ds-ELISA 
The specific detection of virus in infected plant 
samples was highly dependent upon the grinding buffer 
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Figure 8. Detection sensitivity of MDMV-A specific ds-ELISA. Purified MDMV-A ([]--[]) was diluted 
from 1000 to 1.0 ng/ml in PBS and the heterologous virus, MDMV-8 (~)was diluted 
from 10,000 to 1.0 ng/ml in PBS. Each dilution was applied to a microtitration plate 
previously coated with MDMV-A specific capture antibody (MAMXVIII) and blocked with 
BLOTTO. The assay was completed as described in materials and methods and the mean 
A410 value of identical samples was calculated and plotted. A mean value greater than 
0.10 was interpreted as a positive. Data points are the mean values of duplicate 
experiments 
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Figure 9. Detection sensitivity of MDMV-B specific ds-ELISA. Purified MDMV-B (D---{]) was diluted 
from 1000 to 10 ng/ml in PBS and the heterologous virus, MDMV-A (~).was diluted 
from 10,000 to 1.0 ng/ml in PBS. Each dilution was applied to a microtitration plate 
previously coated with MDMV-B specific capture antibody (MBMIII) and blocked with 
BLOTTO. The assay was completed as described in materials and methods and the mean 
A410 value of identical samples was calculated and plotted. A mean value greater than 
0.10 was interpreted as a positive. Data points are the mean values of duplicate 
experiments 
0.60 
0.50 
0.40 
0.30 
A410 
0.20 
0.10 
Virus Concentration (ng/ml) 
115 
utilized during sample preparation. Sample preparation 
for each ds-ELISA was tested using 0. 05M carbonate buffer, 
pH 9.6 (binding buffer), and O.OlM PBS, pH 7.2, containing 
0.05 % Tween 20; each prepared with and without 2.0 % 
BSA . Negative controls included corn tissue infected with 
the heterologous strain and healthy corn tissue. 
The results, presented in Table 7, indicate that 
0.05M carbonate buffer, pH 9.6, containing 2.0 % BSA is 
the optimal grinding buffer when preparing samples for use 
in the MDMV-A specific ds-ELISA. A positive response 
(A410 0.1 greater than PBS control) was also obtained with 
0.05M carbonate buffer, pH 9. 6; however, the addition of 
2.0 % BSA to this buffer increased the positive response 
almost 3-fold . The results, presented in Table 8, indi-
cate that O.OlM PBS, pH 7.2, containing Tween 20 and 2.0 % 
BSA is the optimal grinding buffer when preparing samples 
for use in the MDMV-B specific ds-ELISA. The presence of 
BSA in this buffer gave a positive response 1.5 times 
greater than O.OlM PBS, pH 7.2, contain i ng Tween 20. 
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Table 7. Assay of MDMV infected and healthy corn tissue 
prepared in various grinding buffers for use in 
the optimized MDMV-A specific ds-ELISA 
Tissue sample 
Healthy 
MDMV-B infected 
MDMV-A infected 
PBS control 
Grinding buffersa 
PBS-T PBS-T-BSA Carbonate Carbonate-BSA 
o.005b 
0.008 
0.015 
0.000 
0.005 
0.000 
0.008 
0.000 
0.003 
0.000 
0.140 
0.000 
0.000 
0.000 
0.405 
0.000 
aGrinding buffers included: PBS-T = O.OlM PBS, pH 7.2, 
containing 0.05 % Tween 20; PBS-T-BSA = O.OlM PBS, pH 7.2, 
containing 0.05 % Tween 20 and 2.0 % BSA; carbonate = 
0.05M carbonate buffer, pH 9.6; carbonate-BSA = 0.05M car-
bonate buffer, pH 9.6, containing 2.0 % BSA. 
bResults represented as the mean A410 value of 
identical samples. Values greater than 0.100 indicate 
positive samples. 
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Table 8. Assay of MDMV infected and healthy corn tissue 
prepared in various grinding buffers for use in 
the optimized MDMV-B specific ds-ELISA 
Grinding buffersa 
Tissue sample PBS-T PBS-T-BSA Carbonate Carbonate-BSA 
Healthy o.005b 0.000 0.000 0.000 
MDMV-B infected 0.165 0.238 0.005 0.005 
MDMV-A infected 0.000 0.003 0.000 0.005 
PBS control 0.000 0.000 0. 000 0. 000 
aGrinding buffers included: PBS-T = O.OlM PBS, pH 7.2, 
containing 0.05 % Tween 20; PBS-T-BSA = O.OlM PBS, pH 7.2, 
containing 0.05 % Tween 20 and 2.0 % BSA; carbonate = 
0.05M carbonate buffer, pH 9.6; carbonate-BSA = 0.05M car-
bonate buffer, pH 9.6, containing 2.0 % BSA. 
bResults represented as the mean A410 value of 
identical samples. Values greater than 0.100 indicate 
positive samples. 
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Sensitivity of Optimized ds-ELISA Using Infected 
Plant Tissue 
The level of detection of each ds-ELISA was assessed 
using MDMV infected corn tissue. Tissue infected with the 
homologous strain of MDMV was macerated in a mortar and 
pestle and diluted from 1:10 to 1:5120 in grinding 
buffer. Negative controls included healthy corn tissue 
and tissue infected with the heterologous strain of MDMV, 
also diluted 1:10 to 1:5120 in grinding buffer. Grinding 
buffers utilized to prepare samples for the MDMV-A ds-
ELISA and the MDMV-B ds-ELISA were 0.05M carbonate buffer, 
pH 9.6, containing 2.0 % BSA and O.OlM PBS, pH 7.2, con-
taining 0.05 % Tween 20 and 2.0 % BSA, respectively. 
The results, presented in Figure 10, indicate that 
the MDMV-B ds-ELISA can specifically detect virus in sap 
at dilutions between 1:2560 and 1:5120, whereas the MDMV-A 
ds-ELISA can only specifically detect virus in sap dilu-
tions up to 1:40 (Figure 11). The low detection level 
exhibited by the MDMV-A ds-ELISA was thought to be related 
to pH as samples were diluted in the high pH carbonate 
buffer. This results in an increased pH as the dilution 
of sap increases. The effect of pH on the specific detec-
tion of MDMV-A was therefore determined. 
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Figure 10. Detection sensitivity of MDMV-B specific ds-ELISA using infected plant sap. MDMV-B 
infected ( ~). MDMV-A infected ([]--0), and healthy(()-()) corn tissue were 
macerated in separate mortar and pestles with O.OlM PBS, pH 7.2, containing 0.05 % 
Tween 20 and 2.0 % BSA. Each preparation was diluted 1:10 to 1:5120 in the above 
buffer and applied to a microtitration plate previously coated with MDMV-B specific 
capture antibody (MBMIII) and blocked with BLOTTO. The assay was completed as 
described in materials and methods and the mean A410 value of identical samples was 
calculated and plotted. A mean value greater than 0.10 was interpreted as a positive. 
Data points are the mean values of duplicate experiments 
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Figure 11. Detection sensitivity of MDMV-A specific ds-ELISA using infected plant sap. MDMV-A 
infected (D--[J), MDMV-B infected (~),and healthy(()--()) corn tissue were 
macerated in separate mortar and pestles with 0.05M carbonate buffer, pH 9.6, 
containing 2.0 % BSA. Each preparation was diluted 1:10 to 1:5120 in the above buffer 
and applied to a microtitration plate previously coated with MDMV-A specific capture 
antibody (MAMXVIII) and blocked with BLOTTO . The assay was completed as described in 
materials and methods and the mean A410 value of identical samples was calculated and 
plotted. A mean value greater than 0.10 was interpreted as a positive. Data points 
are the mean values of duplicate experiments 
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MDMV-A infected corn tissue was macerated in a mortar 
and pestle with PBS at a tissue:buffer ratio of 1:20. The 
plant sap was distributed into 8 tubes at 1.0 ml/tube. 
The first tube was set aside. One drop of 1.0N NaOH were 
added to the second tube and 2 drops of 1.0N NaOH was 
added to the third tube. This pattern was continued such 
that the eighth tube contained 7 drops of 1.0N NaOH. The 
pH of each tube was measured using pH paper (Micro Essen-
tial Laboratory, Brooklyn, NY) and two 50 ul samples from 
each tube were applied to 2 wells of a microtitration 
plate previously coated with MDMV-A specific capture 
antibody (MAMXVIII) and blocked with BLOTTO. The assay 
was completed, using procedures previously described, and 
the mean A410 values vs the sample pH was plotted. 
The results presented in Figure 12 indicate that the 
MDMV-A specific ds-ELISA is pH dependent and that the 
optimal sample pH is between 7.5 and 8.5 . 
Assay of Field Isolates for the Presence of MDMV 
Several microtitration plates coated with specific 
IgM capture antibody and blocked with BLOTTO were shipped 
via express mail to out-of-state cooperators. The 
cooperators applied virus infected corn samples to the 
plates using the appropriate grinding buffer and proce-
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Figure 12. Effect of sample pH on the detection of MDMV-A in infected corn tissue. MDMV-A 
infected corn tissue was macerated in a mortar and pestle with PBS. One ml sap 
aliquots were adjusted to various pH values between 6.5 and 11.0 by addition of l.ON 
NaOH. Each sample was applied to a microtitration plate previously coated with MDMV-A 
specific capture antibody (MAMXVIII) and blocked with BLOTTO. The assay was completed 
as described in materials and methods and the mean A410 value of identical samples was 
calculated and plotted . . A mean value greater than 0.10 was interpreted as a positive. 
Data points are the mean values of duplicate experiments 
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dures described previously. The plates were returned and 
analyzed in our laboratory. Results obtained from the 
Iowa isolates and the 2 out-of-state cooperators are 
presented in Table 9. 
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Table 9. Assay of field isolates with MDMV-A specific 
and MDMV-B specific ds-ELISA 1 s 
ds-ELISA A410 valuesa 
Isolate strain 
and designationb Isolate sourcec MDMV-A MDMV-B 
MDMV-B Asgrow 2 Hi 11 0.135 
MDMV-B Asgrow 3 Hi 11 0.190 
MDMV-B Asgrow 4 Hi 11 0.110 
MDMV-B N Kl 99 1 Hil 1 0.185 
MDMV-B NK199 2 Hil 1 0.140 
MDMV-B NK199 3 Hi 11 0.230 
MDMV-B NKl 99 6 Hi 11 0.130 
MDMV-B NK199 7 Hi 11 0.200 
MDMV-B Silver Q 1 Hi 11 0.185 
MDMV-B Silver Q 2 Hi 11 0.130 
MDMV-B Silver Q 3 Hi 11 0.155 
MDMV-B 41F Hill 0.160 
MDMV-B 51F Hi 11 0.140 
MDMV-B Ia 188 Hi 11 0.120 
MDMV-A Hill 0.260 
MDMV-A Jensen 0.340 
MDMV-A Minn 6 Jensen 0.675 
MDMV-A Minn 11 Jensen 0.540 
aEach strain specific ds-ELISA (MDMV-A and MDMV-B) 
was performed as described in materials and methods using 
the appropriate grinding buffer. Results are represented 
as the mean A410 value of identical samples. Positive 
samples are those which have an A410 greater than 0.1. 
Negative samples are represented by --. 
bMaize dwarf mosaic virus (MDMV) and sugarcane mosaic 
virus (SCMV) strains and designations were established by 
previous investigators. 
cinfected isolates from Ankeny, Iowa, were obtained 
by John Hill and Helen Benner and maintained at Iowa State 
University (Hill). Microtitration plates previously 
coated with capture antibody and blocked with BLOTTO were 
shipped to the following out of state cooperat i ves for 
sample application: Stanley Jensen (University of 
Nebraska), and Roy Gingery (Ohio Agricultural Research and 
Development Center). 
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Table 9 (Continued) 
ds-ELISA A410 values 
Isolate strain 
and designation Isolate source MDMV-A MDMV-B 
MDMV-A Ohio od Jensen 0.390 
MDMV-A Ohio E Jensen 
MDMV-A Ohio F Jensen 
MDMV-A Yazoo Miss Jensen 0.120 
MDMV-B Jensen 1.205 
MDMV-B Field B Jensen 0. 740 
MDMV-B Ia 188 Jensen 0.120 
MDMV-B Minn B Jensen 0.460 
MDMV-B Unknown Jensen 
MDMV-KSl Jensen 
SCMV-A Jensen 0.275 
SCMV-B Jensen 
SCMV-B Miss Jensen 
SCMV-H Jensen 
SCMV-M Jensen 
MDMV-A Gingery 0.160 
MDMV-B Gingery 0.410 
MDMV-D Gingery 
MDMV-E Gingery 
MDMV-F Gingery 0.200 
MDMV-0 Gingery 
dJensen refers to MDMV-A Ohio 0, MDMV-A Ohio E, and 
MDMV-A Ohio Fas substrains of MDMV-A; whereas, Gingery 
refers to these same isolates as MDMV strains D, E, and F, 
respectively. 
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DISCUSSION 
Early attempts to produce McAb secreting hybridomas 
were not successful. Therefore, it was necessary to 
modify the fusion and cloning procedures of Van Deusen and 
Whetstone (149) and the immunization procedure described 
by Hill et al. (50). Significant modifications, which 
together resulted in highly successful fusions, included: 
1) increasing the immunization time period and using less 
antigen, 2) decreasing the time of cell exposure to the 
fusogen PEG, 3) increasing the pH of the fusion media used 
to dilute cells following fusion, and 4) using a cloning 
procedure which foregoes cell culture scale-up prior to 
cloning. 
The success of a particular fusion procedure was 
directly related to the specific serum titer of the im-
munized mouse. Use of the immunization procedure 
described by Hill et al. (50) resulted in a serum titer 
between 1:256 and 1:512 and the subsequent spleen cell 
fusion yielded very few hybridomas (2-10 % of the cultured 
wells). However, use of the immunization procedure 
described in this study, which requires half the antigen 
(100 ug vs. 200 ug) administered over a longer period of 
time (7-10 wks vs. 4-6 wks), resulted in serum titers of 
130 
1:12,000 or greater and the spleen yielded successful 
hybridomas in 50-70 % of the cultured wells. Furthermore, 
less than 1.0 % of the successful hybridomas obtained from 
the low titer mouse spleen, secreted immunogen specific 
antibody whereas 75 % of the successful hybridomas ob-
tained from the high titer mouse spleen secreted immunogen 
specific antibody. One reason for the success of this 
immunization procedure may be the stimulation of dividing 
spleen cells, as these are the cells which give rise to 
viable hybridomas (157). 
Although the extended immunization procedure greatly 
enhanced the cell fusion efficiency; certain modifications 
of the fusion procedure described by Van Deusen and 
Whetstone (149) were made to promote the production and 
successful cloning of a greater percentage of viable 
hybridomas. Significant modifications of the procedure 
included short-duration exposure of the fusion mixture to 
PEG and ultilization of fusion media at pH 8.0 rather than 
pH 7.2. These two modifications together increased the 
number of successful hybridomas from 50-70 % to 80-100 % 
of the cultured wells. 
It has been shown that PEG exposure periods greater 
than 60 sec have a detrimental effect upon the number of 
viable hybridomas presumably due to the increased sen-
sitivity of newly formed hybridomas to the cytotoxic 
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effects of PEG (81). Most reported fusion procedures 
recommend a total PEG exposure of 2.0 min or greater(36, 
115, 149, 157, 158), which is well beyond the PEG 
tolerance level of newly formed hybridomas. 
Another fusion procedure modification was an increase 
of the fusion media pH from 7.4 to 8.0. The effect of pH 
on mammalian cell fusion has been investigated by Johnson 
and Rao (71) and Rao and Johnson (114). They found that 
for the successful fusion of two cells, resulting in the 
formation of a binucleate cell, one of two phenomena must 
occur: 1) premature chromosome condensation (PCC) of the 
interphase nucleus or, 2) the formation of a nuclear 
envelope around the metaphase chromosomes. These occur-
rences are highly dependent upon environmental pH; a pH of 
8.0 is optimal for both (71). Therefore, fusion media 
adjusted to this pH results in the maximal number of 
viable hybridomas during cell fusion procedures (157) . 
Using the optimal fusion conditions described above, 
a successful fusion resulted in an average of 500 cultured 
wells containing at least one hybridoma colony. Ap-
proximately 375 or 75 % of these colonies were found to 
secrete specific antibody. Westerwoudt et al. (158) have 
shown that 14 days post-fusion, only 35 % of the original 
positives tested 9 days post-fusion, still produced 
specific antibody. Therefore, it was apparent that a 
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rapid cloning method should be employed such that antibody 
secreting hybridomas would be maintained. 
Several methods exist for the cloning of hybridoma 
cells including limiting-dilution (36, 103), use of solid-
phase supports (4, 149), and single-cell transfer (37). 
However all of these procedures are time-consuming and 
result in the loss of a majority of the antibody producing 
cell lines. The rapid cloning procedure developed in our 
laboratory foregoes the time consuming scale-up procedure 
prior to cloning. Therefore, hybridomas were cloned 
directly from 96-well tissue-culture plates with a suc-
cessful cloning efficiency of 71 %. 
Cell line instability is another major problem com-
monly encountered during hybridoma production. This is a 
result of the temporary increase in chromosome number 
after fusion and the eventual random elimination of 
chromosomes in the hybrid cells. The elimination of 
chromosomes may result in cell death if genes essential 
for growth in tissue culture are lost, or, more commonly, 
loss of antibody production. 
In this study, loss of antibody production was ob-
served during cell cloning procedures and with established 
cell lines maintained for extended periods in continuous 
culture. The cloning procedure resulted in a 29 % loss of 
viable hybridomas. None of the hybridomas failed to grow; 
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rather, the subclones did not secrete or produce 
antibody. Furthermore, several cloned and established 
cell lines ceased to produce antibody after continuous 
culture of 2 weeks or longer. Loss of antibody production 
at this stage is probably not due to the loss of antibody 
producing chromosomes, but may be a result of improper 
regulation (113), failure of a cell line to secrete 
immunoglobulin (16, 87), or excess free heavy chain 
toxicity (78). In any case, Raison et al. (113) have 
demonstrated that mouse-human hybridomas, which ceased 
antibody production, could be restimulated with 
lipopolysaccharide (LPS). Similarly, Gronowicz et al. 
(46) have induced IgM secretion in a murine B-cell tumor 
with LPS. 
Hybridoma cell lines produced in this study secreted 
McAb of the IgM or IgG classes, with a majority secreting 
IgM (Table 1). This result was unexpected, as an extended 
immunization procedure was utilized; therefore, the mouse 
should have been well within the secondary immune response 
when sacrificed. The secondary immune response is 
typified by high IgG titer and low IgM titer. 
Cross-reactivity with the heterologous virus was 
assessed for a majority of the cell lines (Table 1). Most 
of the cell lines developed using MDMV-A as the immunogen 
did not cross-react with the heterologous virus MDMV-B. 
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However, two of the cross-reacting cell lines reacted more 
strongly with the heterologous virus than with MDMV-A. 
This suggests that these particular epitopes are repre-
sented on MDMV-B in greater numbers or are present in an 
environment more favorable for antibody binding. 
Cell lines developed using MDMV-B as the immunogen 
were selected, during initial screening procedures, for 
non-crossreacting antibody secreters. However, of the 
original 260 MDMV-B positive hybridomas only 18 (7 %) did 
not cross-react with the heterologous virus MDMV-A. These 
results suggest that MDMV-B has fewer unique epitopes than 
does MDMV-A. These results also correlate with the 
polyclonal studies of Jarjees and Uyemoto (64). They 
reported polyclonal antisera raised against MDMV-B cross-
reacted strongly with MDMV-A, whereas polyclonal antisera 
raised against MDMV-A cross-reacted only slightly with 
MDMV-B. 
MDMV-A and MDMV-B specific cell lines were further 
characterized by immunoblot analysis of viral coat protein 
to identify different epitope specificities exhibited by 
the McAbs. The assumption is that different immunoblot 
protein binding patterns produced by the McAbs indicates 
that the McAbs are epitypically distinct. Based upon this 
assumption, three different epitopes were identified for 
each virus strain using these procedures (Figure 2 and 
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Table 2). Two MDMV-A specific cell lines (MAMIX and 
MAMXVII) did not bind any viral polypeptides; rather, they 
produced binding patterns identical to the CM negative 
control. This result may be attributed to several fac-
tors: 1) the concentration of McAb produced in culture may 
be below the detection sensitivity of the immunoblot 
procedure, 2) the affinity of the McAbs may be so low that 
the antibody is desorbed during subsequent incubation and 
wash steps, or 3) the McAbs may be restricted to struc-
tural epitopes which are destroyed during viral protein 
proteolysis and SOS-PAGE. 
Protein bands were also identified with the CM nega-
tive control. However subsequent experiments indicated 
that these bands could be observed on a majority of the 
immunoblots and were found to correspond to V8 protease 
bands. It is unlikely that specific recognition of the V8 
protease bands occurred. Rather, the V8 protease may 
inhibit proper blocking of available protein binding sites 
on the nitrocellulose membrane. 
To develop each of the MDMV ds-ELISAs, it was neces-
sary to obtain two epitypically distinct cell lines (50), 
with one secreting IgM and the other secreting IgG. 
Several possible combinations for each MDMV strain existed 
(Table 2). For the MDMV-A ds-ELISA, MAGII was an obvious 
choice as it was the only MDMV-A specific IgG producing 
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cell line analyzed by immunoblot. MAMXVIII was utilized 
as the epitypically distinct IgM producing cell line as 
the lack of viral polypeptide binding exhibited by MAMIX 
and MAMXVII was not fully understood. For development of 
the MDMV-B ds-ELISA, MBGI was utilized as the IgG secret-
ing cell line because it was the only MDMV-B specific cell 
line which secreted the IgG subclass 2b (Table 1). The 
IgG 2b subclass has been shown to produce excellent 
results when purified by protein A sepharose (43). MBMIII 
was utilized as the epitypically distinct IgM producing 
cell line as the immunoblot produced by MBMIII was more 
significantly different from MBGI than those produced by 
MBMII and MBMIV. 
To avoid ELISA background problems associated with 
contaminating proteins, it was necessary to purify the lg 
class from ascitic fluid produced by each respective cell 
line. The purification of IgG from ascitic fluid using a 
protein A sepharose column is a well established and rapid 
procedure (43). The purification of MAGii McAb resulted 
in excellent yields as indicated by the large IgG peak 
depicted in Figure 4a. Purification of MBGI, on the other 
hand, yielded an extremely small IgG peak of low protein 
content (Figure 4b and Table 6), which was proceeded by a 
smaller peak not containing specific IgG activity. 
Results such as this were commonly observed with the Bio-
137 
Rad protein A system and did not seem to be subclass 
related. 
Unlike IgG, a satisfactory procedure for the 
purification of IgM has not existed (43). Ammonium sul-
fate precipitation followed by gel filtration has been 
suggested (43). However, ammonium sulfate also 
precipitates IgG and a low level of IgG polymers could be 
detected in the IgM gel filtration peak (results not 
presented). Contaminating mouse IgG in the IgM prepara-
tion will bind to wells of the microtitration plate during 
IgM coating procedures. Therefore, when rabbit anti-mouse 
IgG conjugated antibody was added in subsequent steps, 
bound mouse IgG would be detected in the absence of 
virus. Thus resulting in high background absorbances or 
false positives. 
To alleviate this problem, IgM was specifically 
concentrated by precipitation with a 2 % boric acid 
solution. Boric acid effectively precipitated IgM because 
of it's low ionic strength, low pH of the boric 
acid:ascitic fluid mixture, and the propensity of boric 
acid to form insoluble complexes with carbohydrates (39). 
The IgM molecule consists of approximately 12 % car-
bohydrate as compared to IgG which contains only 2 % 
(102). Boric acid precipitation of IgM, followed by 
sepharose CL-68 gel filtration, resulted in a McAb 
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preparation free of mouse IgG. 
Sepharose CL-6B gel filtration generated three detec-
table peaks at fractions 10, 25-30, and 45-50. These 
peaks are represented by the solid lines in Figures 3a and 
3b. The greatest amount of specific, biologically active 
IgM was obtained in the first peak (broke~ lines in 
Figures 3a and 3b). The second and third peaks may repre-
sent biologically active, dissociated forms of the IgM 
pentamer. 
When each McAb was obtained in purified form, the 
ELISA systems were optimized. Optimal concentrations of 
purified monoclonal IgM, purified monoclonal IgG, and 
rabbit anti-mouse IgG enzyme conjugated antibody were 
determined by calculating and plotting the P to N ratios 
for each antibody preparation. The optimal concentrations 
used in each system were comparable as depicted in Figures 
5, 6, and 7. 
Once optimized, the detection sensitivity of each ds-
ELISA was assessed using purified virus and virus infected 
corn tissue. The detection sensitivity of the MDMV-B 
system using purified virus was 32 ng/ml or 1600 pg/well 
(Figure 9). The sensitivity of the MDMV-A ds-ELISA was 
between 16 and 8 ng/ml or 800 and 400 pg/well (Figure 8). 
However, when MDMV-A infected corn plants were prepared in 
PBS, no virus was detected by the MDMV-A ds-ELISA. As 
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indicated above, the assay was extremely sensitive; thus, 
it was thought that epitopes on the virus in plant samples 
were not presented to the IgM capture antibody or the IgG 
second antibody in a recognizable form. Therefore, a high 
pH carbonate buffer was investigated as a possible grind-
ing buffer in an attempt to expose putative cryptotopes 
which may be recognized by the capture and second 
antibodies. As expected, the MDMV-A ds-ELISA specifically 
detected virus when MDMV-A infected corn tissue was 
prepared in carbonate buffer (Table 7). Furthermore, when 
2.0 % BSA was added to carbonate buffer, the mean A410 of 
MDMV-A infected samples nearly tripled in addition to a 
complete elimination of background absorbances. The 
decrease in background was expected; however, the in-
creased specific absorbance was somewhat surprising and 
still unexplained. The same result, although not as 
dramatic, was observed when BSA was added to grinding 
buffer used for MDMV-B infected sample preparations (Table 
8). PBS-Tat pH 7.2 could be used as the grinding buffer 
to detect MDMV-B in leaf samples. This suggests that the 
MDMV-B system recognizes native, intact virions. 
Using the appropriate grinding buffer as a diluent, 
the detection sensitivity of each ds-ELISA was assessed 
using dilutions of virus infected plant tissue. The MDMV-
B system proved to be extremely sensitive as virus was 
140 
detected at sap dilutions between 1:2560 and 1:5120 
(Figure 10). The MDMV-A system on the other hand, could 
only detect virus at sap dilutions up to 1:40 (Figure 
11). This result was unexpected, as the MDMV-A system was 
previously shown to detect less than 800 pg of purified 
virus per well (Figure 8) . This loss of sensitivity at 
high sap dilutions was thought to be related to the pH of 
the diluted plant sap as all dilutions for the MDMV-A 
system were performed in a high pH carbonate buffer. To 
further investigate the effect of pH on the MDMV-A ds-
ELISA, MDMV-A infected sap was diluted to 1:20 and ad-
justed to various pH values between 6.5 and 11.0 before 
application to the microtitration plate. This experiment 
demonstrated that the MDMV-A system has a strict pH re-
quirement and can only detect virus in sap at a pH between 
7. 5 and 8.5 (Figure 12). These results explain the lack 
of sensitivity demonstrated by the MDMV-A system at high 
sap dilutions. The pH of dilutions greater than 1:40 were 
above 9.0 and thus not within the optimal range of the 
MDMV-A system. These results and the results presented 
previously in Table 7, indicate that a pH greater than 7.5 
was necessary to liberate the cryptotope; however, at a pH 
greater than 8.5 the epitope is somehow altered and thus 
undetected by the MDMV-A system. 
In summary, the MDMV-A ds-ELISA was performed under 
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the following conditions: 1) the optimal dilutions of 
coating IgM (MAMXVIII), second antibody (MAGI!), and 
enzyme conjugated antibody were 1:800, 1:200, and 1:2000, 
respectively, and 2) samples were prepared in 0.05M car-
bonate buffer, pH 9.6, containing 2.0 % BSA, at a dilution 
no greater than 1:40. The MDMV-B ds-ELISA was performed 
under these conditions: 1) The optimal dilutions of coat-
ing IgM (MBMIII), second antibody (MBGI), and enzyme 
conjugated antibody were 1:1600, 1:400, and 1:2000, 
respectively, and 2) samples were prepared in O.OlM PBS, 
pH 7.2, containing 0.05 % Tween 20 and 2.0 % BSA. 
The specificity of each fully defined and optimized 
ds-ELISA was assessed using tissue infected with various 
MDMV and SCMV isolates. Each system accurately detected 
virus in samples infected with the homologous virus. The 
MDMV-B ds-ELISA could detect virus in 18 of 19 (95 %) 
samples infected with MDMV-B and the MDMV-A ds-ELISA 
detected virus in 7 of 9 (78 %) samples infected with 
MDMV-A (Table 9). The three samples not detected by the 
two assays were prepared by out-of-state cooperators. 
Therefore, the lack of detection may be a result of 
microtitration plate shipping and storage, improper sample 
preparation, or incorrect initial virus strain 
designation. Furthermore, Jensen's MDMV-A substrains Ohio 
D, Ohio E, and Ohio F, were originally obtained from 
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Gingery and correspond to Gingery's MDMV-D, MDMV-E, MDMV-
F, respectively. The only difference is that Jensen 
refers to MDMV-D, MDMV-E, and MDMV-F as MDMV-A substrains 
Ohio D, Ohio E, and Ohio F, respectively, whereas Gingery 
recognizes MDMV-D, MDMV-E, and MDMV-F as distinct strains 
of MDMV. If we were to accept Jensen's strain subdivi-
sions, the MDMV-A ds-ELISA would be 78 % accurate because 
two of Jensen's MDMV-A substrains obtained from Gingery 
(MDMV-A Ohio E and MDMV-A Ohio F), did not react in the 
MDMV-A ds-ELISA. Alternatively, if we accept Gingery's 
designations, the system recognized MDMV-A and MDMV-F. 
In our hands, the assay systems could detect 
homologous virus with high assurance. The MDMV-A system 
was found to react with the MDMV-A Ohio D strain supplied 
by Jensen and cross-react with the MDMV-F strain of Gin-
gery (Table 9). However the MDMV-D strain supplied by 
Gingery and the MDMV-A Ohio F strain supplied by Jensen 
did not react in the MDMV-A ds-ELISA as did the MDMV-A 
Ohio D strain supplied by Jensen and the MDMV-F strain 
supplied by Gingery. Since MDMV-A Ohio D (Jensen) and 
MDMV-D (Gingery) as wel 1 as MDMV-A Ohio F (Jensen) and 
MDMV-F (Gingery) are assumed to originate from the same 
source, a mix-up of cultures supplied by the inves-
tigators, or a mutation in the coat protein gene has 
occurred causing a change in epitope express i on. 
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Louie and Knoke (90) have previously demonstrated the 
serological relationship between MOMV-A, MOMV-0, and MOMV-
F. They also noted that MOMV-A is serologically related 
to strain E of MOMV; however, cross-reactivity with this 
strain was not observed in this study. Thus suggesting 
that the McAbs utilized in the MOMV-A system may be 
specific for epitopes shared by MOMV-A, MOMV-0, and MOMV-
F, which are distinct from common epitopes which may exist 
between MOMV-A and MOMV strain E. The MOMV-B ds-ELISA was 
found to strongly cross-react with SCMV-A. The serologi-
cal relationship between MOMV-B and SCMV-A has also been 
well established and the strains have been placed in the 
same serogroup (64, 145). 
The goal of this study was to develop a McAb based 
ds-ELISA which could specifically distinguish the 
serologically related MOMV strains A and B. Although 
cross-reactivity with SCMV-A, MOMV-0, and MOMV-F was 
observed, this cross-reactivity should not diminish the 
value of the ds-ELISAs for the following reasons. First, 
maize grown adjacent to sugarcane may become infected with 
SCMV-A; however, symptom development and crop damage 
seldom occurs (109). Therefore, plants infected with 
SCMV-A will most likely be by-passed when collecting field 
samples. In addition, MOMV-0 and MOMV-F are rarely ob-
served in the field and thus would not significantly alter 
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observed in the field and thus would not significantly 
alter the effectiveness of the MDMV-A ds-ELISA (141). 
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